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Welcome to the fifth Very Low Birth 
Weight Infants in the Republic of Ireland 
(ROI) Annual Report, produced by the 
Neonatal Intensive Care Outcomes 
Research and Evaluation (NICORE) ROI 
group and facilitated by the National 
Perinatal Epidemiology Centre (NPEC). This 
report focuses on all babies born ≤1500g 
and/or ≤29 weeks gestation in the Republic 
of Ireland for the calendar year 2018 and 
compares outcomes to the preceding four 
years.
Data on every Very Low Birth Weight 
(VLBW) infant born in the ROI during 
the years 2014 to 2018 is now available: 
this is just under 3,000 infants and is a 
remarkable achievement, made all the more 
pertinent by the fact that we are one of 
very few countries reviewing outcomes of 
care of VLBW infants at a national level. 
Of note, in this year’s report is the 
reduction in the number of VLBW infants 
born in the Republic of Ireland in 2018. 
In total, 537 VLBW infants were born, 
a 14% reduction from a peak of 622 
infants in 2015. This may be reflective 
of the reduction in the total number of 
liveborn infants in Ireland, the latter having 
decreased by 10% from 2014 to 2018 (from 
67,285 birth in 2014 to 61,016 birth in 2018). 
This trend will be followed with interest in 
the coming years as it may have significant 
implications on how neonatology services 
are planned into the future. In 2018, the vast 
majority (89%) of infants born at 23 weeks 
were offered resuscitation in the Delivery 
Room (DR) – an increase from 43% for 
infants of the same gestational age born 
in 2014. Unfortunately, only 33% of these 
infants survived to discharge home. The 
Clinical Lead Programme in Neonatology, 
the Neonatal Clinical Advisory Group of 
the Faculty of Paediatrics, the Institute 
of Obstetrics and Gynaecology and The 
National Women and Infants’ Programme 
are currently working on a Framework 
for Practice document on the “Perinatal 
Management of Extreme Preterm Birth at 
the Threshold of Viability”. The publication 
of this document is eagerly awaited. The 
findings of our yearly reports, in addition 
to our 3 year report on the Mortality Risk 
among VLBW born between the Years 
2014-2016 have been made available to all 
the above parties for their consideration. 
As mentioned in last year’s report, 
the primary focus of the NICORE ROI 
group remains on obtaining detailed 2 
year neurodevelopmental follow up on 
our VLBW infants. Families facing the 
imminent delivery of a very premature 
baby, particularly an infant born at the 
limits of viability, need accurate and up to 
date information not only on the chances 
of survival but also on the long term 
neurodevelopmental outcome. A Bayley 
Assessment of Infant Development at 2 
years of age remains the gold standard in 
neonatology. Recent discussions among 
our NICORE member centres indicate that, 
in the vast majority of cases, even in the 
larger tertiary neonatal centres, neither 
the staff nor the financial resources are 
available to undertake this vital work. This is 
not just about accumulating good outcome 
data to expand our yearly report but what 
is even more critical is that these vulnerable 
infants, who are at high risk of long 
term neurodevelopmental problems, are 
diagnosed as early as possible and referred 
to community based Early Intervention 
Services as soon as possible. We submitted 
a business case to the Women and 
Infants’ programme in 2019 and have been 
informed that some funding has been made 
available for this important work. We are 
awaiting more definitive information but we 
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This report is based on data submitted by 
all 19 neonatal centres in the ROI. Another 
milestone for us in 2018 is that one of 
the two paediatric tertiary centres in the 
Republic of Ireland, namely CHI, Temple 
Street, has joined VON. This means that we 
are now in a position to gather even more 
important clinical outcome information on 
that subgroup of VLBW infants who require 
tertiary medical and surgical services that 
are only provided in paediatric centres. 
This report would not be possible without 
the many neonatal nurses, paediatricians 
and administration staff who have 
supported the data collection process and 
we gratefully acknowledge the commitment 
of all those individuals. We thank the team 
at Vermont Oxford Network who continue 
to whole-heartedly support this initiative 
by working closely with the NPEC on data 
collection and statistical analysis. We thank 
the National Office of Clinical Audit (NOCA) 
for their continuing support to NPEC in 
ensuring that recommendations arising 
from national clinical audit are reviewed 
and actioned: this report, similar to previous 
reports, is endorsed by NOCA (Appendix 
A). We extend our sincere thanks to the 
NPEC, led by Professor Richard Greene, 
for its continued support of the ROI’s 
participation in VON, specifically by 
financing the annual membership fee on 
behalf of all 20 centres and for providing 
the logistical support required to oversee 
this project. 
To our fellow members of the NICORE 
ROI group, we appreciate their support 
of this project from the onset. They have 
been instrumental in supporting our 
endeavour to expand our collection of data 
to include neurodevelopmental outcome. 
The membership of NICORE ROI is listed in 
Appendix B. 
On a final note, this initiative of the ROI 
neonatal community to review its outcomes 
of care at both local and national levels 
demonstrates its commitment to improving 
outcomes for all VLBW infants in the ROI 
and their families. By continuing to assess 
the outcomes of care, learning from the 
data and working together, we have great 
potential to improve the outcomes of 
VLBW infants in Ireland.
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Executive Summary
1.  A total of 537 very low birth weight 
(VLBW) infants were born in the Republic 
of Ireland (ROI) in 2018, of which 19 
infants had a birthweight >1500g, all of 
these were ≤29 weeks 6 days gestation.
2.  In all, 239 infants were born with a birth 
weight ≤1000g and 182 infants were born 
with a gestational age ≤26 weeks 6 days.
3.  The crude survival rate for ROI VLBW 
infants in 2018 was 82% (n=435, survival 
information not available for seven 
infants). At least 75% of the VON units 
had higher survival than reported by the 
ROI for 2018 (VON Median 88%; Q1=83%, 
Q3=93%).
4.  Adjusting for the risk profile of the VLBW 
population, the risk of mortality remains 
higher in the VLBW ROI population in 
2018 (SMR=1.11; 95% CI: 0.87, 1.36) but 
this was not statistically significant. This 
finding is consistent with previous years. 
5.  Similarly, the risk of mortality excluding 
early deaths (deaths in the delivery room 
or deaths within 12 hours of admission to 
the NICU) in the VLBW ROI infants is also 
higher in 2018 (SMR=1.12; CI 0.83, 1.41), 
but again, this finding was not statistically 
significant. 
6.  There is no significant difference in 
the risk of death or morbidity for ROI 
infants compared to VON infants in 2018 
(SMR=1.01, 95% CI: 0.88, 1.15). This is in 
line with 2017 but is in contrast to the 
two preceding years when ROI infants 
had significantly higher rates of death or 
morbidity.
7.  Again, adjusting for the risk profile of 
the VLBW population, Key Performance 
Indicators in the neonatal care of VLBW 
infants born in the ROI in 2018 compared 
to VON infants showed that: 
 •  ROI infants had significantly higher 
rates of Pneumothorax (SMR=1.56, 95% 
CI: 1.13, 1.98). This has been reported 
each year since the commencement 
of this audit in 2014. In particular, ROI 
infants born at 28-31 weeks gestation 
have a risk of pneumothorax more than 
twice that expected (SMR=2.25; 95% 
CI: 1.95, 2.56). To better understand 
this elevated risk of pneumothorax 
amongst ROI infants, further in-depth 
analysis using data accumulated over 
multiple years will be carried out.
 •  ROI infants had lower rates of 
retinopathy of prematurity (SMR=0.85, 
95% CI: 0.67, 1.04) but this finding 
was not statistically significant as in 
previous years (2014-2017). However, 
in 2018, ROI infants had significantly 
lower rates of severe retinopathy of 
prematurity (SMR=0.39, 95% CI: 0.0, 
0.83), it is the first year that we have 
reported such a finding. 
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 •  There were no significant differences 
in risk of the following outcomes for 
ROI infants compared to VON infants:
  –  Late bacterial infection (SMR=0.88, 
95% CI: 0.56, 1.20) as recorded in 
previous years;
  –  Coagulase negative Staphylococcus 
infection (SMR=1.20, 95% CI: 0.80, 
1.61), in line with previous years;
  –  Nosocomial infection (SMR=0.97, 
95% CI: 0.71, 1.24), similar to findings 
in previous years; 
  –  Intra-ventricular haemorrhage 
(SMR=0.99, 95% CI: 0.80, 1.17), in line 
with the past two years; 
  –  Necrotizing enterocolitis (NEC) 
(SMR=1.22, 95% CI: 0.83, 1.61). This 
is in contrast to the two preceding 
years when ROI infants had 
significantly higher rates of NEC.
 •  Of note, in 2014-2015, there was 
a higher-than-expected risk of 
coagulase negative infection, 
nosocomial infection and any late 
infection. This elevated risk has 
diminished over time so that currently 
the observed and expected number 
of cases are now similar. As multiple 
years of data are now available, it may 
be possible to investigate and better 
understand this improvement.
8.  In 2018, of the 537 infants born, 73% 
(n=393) were born in tertiary neonatal 
centres; 19% (n=101) were born in regional 
neonatal centres; and 8% (n=43) were 
born in peripheral centre. Of those born 
outside tertiary centres, 30 of these were 
transferred within 48 hours of being born.
9.  A total of 30 ROI infants died in the 
delivery room (6%). The VON median 
for delivery room deaths is 0% (Q1=0%, 
Q3=4.5%), hence, at least 75% of the 
VON units had a lower percentage of 
delivery room deaths than reported in 
ROI for 2018. Seven (23%) of these 30 
ROI infants who died in delivery room 
had a major congenital anomaly and 21 
(70%) were born at less than 24 weeks 
gestation.
10.  Of all infants born between 23 and 27 
weeks gestation (n=218), 174 (80%) were 
born in a tertiary neonatal centre, 21 
(10%) were born in a regional neonatal 
centre and 23 (11%) were born in a 
peripheral centre. This compares to 167 
(80%) of a total of 210 infants born at 
this gestation in tertiary centres in 2017 
and 85% (n=178) in 2016. The current 
Model of Care for Neonatal Services in 
Ireland recommends that infants before 
28 weeks should ideally be delivered at a 
tertiary neonatal centre.
11.  In 2018, 72% of infants received active 
resuscitation at birth in the delivery 
room. The proportion was similar at 70% 
in 2017 and 75% in 2016. The 2018 report 
on mortality risk among VLBW infants 
between 2014-2016 recommended that 
resuscitation should be administered to 
all infants born at 23 weeks who present 
in a favourable condition. In 2018, 89% 
of infants born at 23 wks gestation were 
offered resuscitation compared to 42% 
in 2014. 
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The Vermont Oxford Network (VON) is a non-
profit voluntary collaboration of health care 
professionals dedicated to improving the quality 
and safety of medical care for newborn infants 
and their families. More information on this 
Network can be found on their webpage:  
https://public.vtoxford.org/ . Established in 1988, 
the Network is today comprised of more than 
1300 Neonatal Intensive Care Units around the 
world (Figure 1).
The Network maintains a database of information 
regarding the care and outcomes of high-risk 
newborn infants. The database provides unique, 
reliable and confidential data to participating 
units for use in quality management, process 
improvement, internal audit and peer review.
In the ROI, nine tertiary and regional neonatal 
centres had joined VON by 2003, followed by the 
remaining 10 centres in 2013. This was on foot of 
a joint initiative between the NICORE group and 
the NPEC. In 2014, all 19 neonatal centres in the 
ROI submitted data to VON, signifying the first 
year for which a national dataset is available. The 
first annual report on all VLBW infants born in the 
Republic of Ireland was subsequently published 
for the year 2014. The current report represents 
the fifth year, 2018, of a complete ROI dataset. 
Member Countries
Figure 1: Member countries of the Vermont Oxford Network. 
Background 
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Figure 2: Neonatal 
centres in the Republic 
of Ireland and Northern 
Ireland participating in the 
Vermont Oxford Network. 
ROI centres are classified 
according to category of 
Neonatal Units and the 
hospital group to which 
they are affiliated. 
For the ROI, data submitted to VON are 
controlled by NICORE (Neonatal Intensive Care 
Outcomes Research and Evaluation) ROI, a group 
of consultant neonatologists and paediatricians 
with formal representation from all 19 tertiary, 
regional and peripheral neonatal centres in 
the Republic. NICORE ROI is formally affiliated 
through a Memorandum of Understanding to 
the Faculty of Paediatrics, Royal College of 
Physicians of Ireland (RCPI). NICORE ROI is also 
formally affiliated to and functions in partnership 
with the National Perinatal Epidemiology Centre 
(NPEC) for the promotion and management of 
VON in the ROI. 
NICORE ROI, incorporating all neonatal centres in 
the Republic, collaborates with the five neonatal 
centres in Northern Ireland (NI). This cross-
border collaboration has been in existence since 
2003 when only nine centres in the ROI were 
contributing data to VON. The collaborative 
group at that time was identified as NICORE 
Ireland. When all 19 centres in the ROI began 
submitting data to VON, the NICORE ROI 
group was created. Effectively, NICORE ROI is a 
subgroup of the parent group, NICORE Ireland. 
Figure 2 illustrates all units participating in VON 
in the island of Ireland according to the category 
of their Neonatal Units and the hospital group to 
which they are affiliated. 
Governance 
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Data recording
In 2018, 19 neonatal centres participated in the VON’s Very Low Birth Weight (VLBW) 
database. The definition of eligibility for the VLBW database is:
Any infant who is born alive at a hospital whose birth weight is between 401 and 
1500 grams OR whose gestational age is between 22 weeks 0 days and 29 weeks 
6 days (inclusive), regardless of where in the hospital the infant receives care. 
Anonymised data on VLBW infants born between 1st January and 31st December 2019 
were submitted to VON’s on-line database - eNICQ (Please see Appendix C for data 
collection forms). Figure 3 illustrates the flow of information involved. 
Figure 3: Flow of information and data management in the VON data collection process. 
On completion of all ROI submissions for 2018, VON forwards a copy of the complete 
ROI dataset to the NPEC. The ROI data presented in this report are based on the ROI 
dataset. Throughout the report, ROI data are compared to VON data, comprising data 
from all centres across the Network. The Network data, referred to as VON data, are 































The VON database allows the capture of a data 
record from the birth centre of all VLBW infants. 
It also allows the capture of a record from the 
first centre to which an infant was transferred, 
where applicable. In cases of infants who were 
treated in more than two centres, the VON 
database does not capture a record from the 
second transfer centre, and thus these infants 
have two records only, one from the birth centre 
and the other from the first transfer centre. On 
receipt of the ROI 2018 dataset from VON, the 
NPEC undertook a matching exercise in order 
to link data records associated with individual 
infants who were transferred (matching the 
record of the unit where the infant was born with 
the record of the unit to where the infant was 
transferred) in order to ensure that each infant 
was counted only once.
Secondly, for the purpose of completion of data, 
in order to ensure that all infants which met the 
VLBW inclusion criteria in 2018 were captured in 
the dataset, the dataset was cross-checked with 
the NPEC’s National Clinical Audit of Perinatal 
Mortality 2018 dataset. Early neonatal deaths, 
between 401g and 1500g or whose gestational 
age was between 220/7 and 296/7, even if never 
admitted to an NICU/SCBU, are eligible for 
reporting to VON. In cases of early neonatal 
deaths which met the VON criteria but were 
not captured in the VON dataset, the relevant 
neonatal centre was requested to complete 
and submit a record. The ROI dataset was 
subsequently updated.
Statistical analysis
Differences in proportions were assessed by 
the two-sample test of proportions. Pearson’s 
chi-squared test (χ2) was used to evaluate the 
association between outcomes and gestational 
age categories. Poisson regression was used to 
assess trend.
Reference to Very Low Birth 
Weight Infants in the Republic of 
Ireland Annual Report 2014 and 
2015 
Since publication of the 2014 and 2015 reports, 
the matching exercise described above was 
undertaken on the 2014 ROI dataset. This had the 
effect of reducing the number of VLBW infants 
born in the ROI in 2014 from 608, as described 
in the 2014 and 2015 reports, to 597. The current 
report utilises the most accurate values for 2014 
ROI data and hence differs slightly from the 
values stated in the 2014 and 2015 reports. Values 
for 2015 data have not changed since publication 
of the 2015 report. 
Comparing ROI Percentages 
with Medians reported by the 
VON 
Although in previous reports it was possible to 
compare the percentages of specific measures 
(e.g. KPIs, mortality, among others) for infants 
born in the ROI with the percentages reported 
for VON infants, from 2018, VON no longer 
reports on the percentages for the whole 
network. Instead, VON reports the median 
percentage (the percentage at the median 
hospital in the network) along with the 1st and 
3rd quartile percentages (Q1 and Q3) and it 
will be these values that are now presented in 
our tables. To interpret these values, 50% the 
units in VON will report a lower percentage 
than the median, 25% of the units report a lower 
percentage than Q1 and 75% of the units will 
report a lower percentage than Q3.
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Reliability of conclusions based 
on small numbers
Population rates and percentages are subject 
to random variation. This variation may be 
substantial when the measure, such as a rate, 
has a small number of events in the numerator 
or denominator. Typically, rates based on large 
numbers provide stable estimates of the true, 
underlying rate. Conversely, rates based on 
small numbers may fluctuate dramatically from 
year to year, or differ considerably from one 
centre to another, even when differences are not 
meaningful. Meaningful analysis of differences 
in rates between geographic areas or over time 
requires that the random variation be quantified 
and that multiple years of data be incorporated. 
It is correct to present rates which are based 
on rare outcomes and small numbers as this is 
what the data shows, but conclusions cannot be 
drawn from rates and outcomes based on small 
numbers.
Definitions and terminology
Any Late Infection: Indicates whether the infant 
has either any late bacterial infection, coagulase 
negative infection and/or fungal infection after 
day 3 of life.
Any Intraventricular Haemorrhage (IVH): 
Indicates whether the infant has a grade 1, 2, 3 
or 4 periventricular-intraventricular hemorrhage 
(PIH) on or before day 28.
Birth weight: Weight from the labour and 
delivery record. If this is unavailable, weight 
on admission to the neonatal unit or lastly, the 
weight obtained on autopsy (if the infant expired 
within 24 hours of birth).
Chronic Lung Disease (CLD): Based on an 
algorithm that was tested with hospital data and 
is more accurate than just oxygen dependency 
at 36 weeks gestational age. CLD is coded 
‘yes’ if the infant is in your centre at 36 weeks 
postmenstrual age and ‘oxygen at 36 weeks’ 
is answered ‘yes’. Infants are considered to ‘be 
in your centre at 36 weeks’ if they have not 
been discharged home on that date or if they 
have been transferred from your centre to 
another centre prior to the date of week 36 but 
have been readmitted to your centre before 
discharge home, death or first birthday or are not 
transferred a second time before 36 weeks. 
If the infant is discharged home on or after 34 
weeks postmenstrual age but before 36 weeks, 
then CLD is equal to the ‘value of oxygen at 
discharge’. The latter is recorded as ‘yes’ for 
infants who went home and were on oxygen 
at the time of discharge. If the infant was 
transferred to another hospital on or after 34 
weeks postmenstrual age but before the date 
of week 36, then CLD is equal to the ‘value of 
oxygen at the time of discharge’ from your 
institution. Again, the latter is recorded as ‘yes’ 
for infants who were transferred and were on 
oxygen at the time of discharge from your centre. 
If the infant is discharged home before 34 
weeks postmenstrual and is not on oxygen at 
the time of discharge, then CLD is coded as 
‘no’. If the infant is transferred before 34 weeks 
postmenstrual age and the infant is not on 
oxygen at discharge, then CLD is coded as ‘no’. 
However, if the infant is discharged home or 
transferred to another hospital before 34 weeks 
postmenstrual age, and the infant is on oxygen at 
the time of discharge from our centre, then CLD 
is coded as ‘unknown’.
Chronic Lung Disease (CLD) < 33 weeks 
gestation: The same algorithm applied as above 
but only includes infants < 33 weeks gestation. 
Coagulase Negative Infection: Coagulase 
negative Staphylococcus recovered from a blood 
culture obtained from either a central line or a 
peripheral blood sample, and/or recovered from 
cerebrospinal fluid obtained by lumbar puncture, 
ventricular tap or ventricular drain after day 3 
of life AND one or more signs of generalized 
infection AND treatment with 5 or more days of 
intravenous antibiotics. 
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Cystic Periventricular Leukomalacia (PVL): 
Evidence of cystic periventricular leukomalacia 
on a cranial ultrasound, CT, or MRI scan obtained 
at any time prior to discharge.
Death or morbidity: Indicates if an infant died 
or was known to have one or more of the 
following key morbidities: severe intraventricular 
haemorrhage (IVH), chronic lung disease (CLD) 
in infants <33 weeks, necrotising enterocolitis 
(NEC), pneumothorax, any late infection or cystic 
periventricular leukomalacia (PVL). 
Died in the delivery room: Death of a live born 
baby who was never admitted to the NICU, and 
died in the delivery room or at any other location 
in your hospital within 12 hours after birth.
Fungal Infection: Fungus recovered from a blood 
culture obtained from either a central line or a 
peripheral blood sample after day 3 of life.
Gestational age: The best estimate of gestational 
age in weeks and days using the following 
hierarchy: 
–  obstetric measures based on last menstrual 
period, obstetrical parameters, and prenatal 
ultrasound as recorded in the maternal chart.
–  neonatologist’s estimate based on physical 
criteria, neurologic examination, combined 
physical and gestational ages exam (Ballard or 
Dubowitz), or examination of the lens.
Inborn: Infant delivered at the hospital 
submitting the VON data.
Key Performance Indicators (KPIs): VON 
reports on a number of Key Performance 
Indicators (KPIs) which allow the ROI to compare 
its outcomes to VON as a whole. Further 
information on this is available on section 4 of 
the report (4. Key Performance Indicators) on 
page 19.
Late Bacterial Infection: Bacterial pathogen 
recovered from blood and/or cerebrospinal fluid 
culture obtained after day 3 of life. 
Mortality: Indicates whether the infant died.
Mortality excluding early deaths: Death 
excluding those who died in the Delivery Room 
or within 12 hours of admission to the NICU.
Necrotising Enterocolitis (NEC): NEC diagnosed 
at surgery, at post-mortem examination or 
“clinically and radiographically”. To be diagnosed 
“clinically and radiographically”, there has to be 
at least one of the following clinical signs present: 
bilious gastric aspirate or emesis; abdominal 
distension; occult or gross blood in stool AND at 
least one of the following radiographic findings 
present: pneumatosis intestinalis, hepato-biliary 
air, pneumoperitoneum.
Nosocomial Infection: Indicates whether the 
infant has either late bacterial infection and/
or coagulase negative Staphylococcal infection 
diagnosed after day 3 of life. 
Outborn: Infant delivered outside the hospital 
submitting the VON data. Any infant requiring 
ambulance transfer is considered outborn.
Pneumothorax: Extra-pleural air diagnosed 
by chest radiograph or needle aspiration 
(thoracentesis).
Retinopathy of Prematurity (ROP): Indicates 
whether the infant has stage 1, 2, 3, 4 or 5 ROP.
Resuscitation: Defined, for the purposes of this 
report, as the administration of any positive 
pressure breaths via a face mask ventilation and/
or via an endotracheal tube in the delivery room 
or in the initial resuscitation area.
Severe Intraventricular Haemorrhage (IVH): 
Indicates whether the infant has a grade 3 or 
4 periventricular-intraventricular haemorrhage 
(PIH) on or before day 28.
Severe Retinopathy of Prematurity (ROP): 
Indicates whether the infant has stage 3, 4 or 5 
ROP. 
Survival without Specified Morbidities: Indicates 
whether the infant survived with none of the 
following key morbidities: Severe IVH, CLD 
Infants <33 Weeks, NEC, Pneumothorax, Any 
Late Infection, or PVL. 
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Main findings 
1. Overview
A total of 537 VLBW infants were reported to 
VON in Ireland in 2018, constituting infants born 
in all 19 maternity centres and their affiliated 
Neonatal Intensive Care Units (NICUs) in the 
Republic of Ireland (ROI). In 2018, data on infants 
transferred within 28 days of life to one of the two 
tertiary paediatric centres in the ROI were also 
reported to VON. Overall, 62,135 VLBW infants 
were reported to the VON Network in 2018.
Overall, there has been a 10% decrease in the 
number of very low birth weight infants recorded 
in Ireland in the past 5 years (Table 1.1). This is in 
line with the 10% reduction in the number of births 
in Ireland between 2014 and 2018 (from n=67,285 
to n=61,016).1
As shown in table 1.1, outlining the gestational age 
of infants reported in 2018, the highest proportion 
of infants were born in the 27-29 weeks gestation 
(37%, n=198). A total of 44 (8%) infants were born 
with a gestation below 24 weeks and 31 (6%) 
infants were born with a gestation of more than 32 
weeks. In total, 8% (45 out of 537) of VLBW infants 
born in 2018 had a major congenital anomaly 
(MCA) compared to the same proportions (8%) 
in 2017, 9% (54 out of 593) in 2016, 7% (42 out of 
622) in 2015 and 9% (55 out of 597) in 2014. 
Table 1.1: Number of cases reported to VON 2014 – 2018 in Ireland, according to gestational age. 
Gestational age
All cases No. of cases with MCA
2014 2015 2016 2017 2018 2014 2015 2016 2017 2018
<24 weeks 41 48 48 38 44 0 0 3 1 1
24-26 weeks 114 114 134 125 138 9 11 12 12 10
27-29 weeks 235 235 217 240 198 19 14 20 19 16
30-32 weeks 159 170 152 172 126 20 10 15 11 10
>32 weeks 48 55 42 37 31 7 7 4 8 8
Total 597 622 593 612 537 55 42 54 51 45
Note: MCA=Major Congenital Anomaly. MCA was unknown for 1 infant in 2014 and 2 infants in 2018.
Table 1.2: Number of cases reported to VON in 2014 – 2018 in Ireland, according to birth weight.
Birth weight (g)
All cases No. of cases with MCA
2014 2015 2016 2017 2018 2014 2015 2016 2017 2018
<501 26 23 21 23 24 1 0 1 2 0
501 – 750 85 100 104 93 97 3 5 14 8 8
751 – 1000 115 98 125 122 118 15 14 11 12 8
1001 – 1250 154 155 152 157 132 15 10 14 12 12
>1250 216 246 191 217 166 21 13 14 17 17
Total 596 622 593 612 537 55 42 54 51 45
Note: MCA=Major Congenital Anomaly; one infant in 2014 (Birthweight 501-750g) did not have a recorded birth weight.  
MCA was unknown for 1 infant in 2014 and 2 infants in 2018.
In terms of birth weight, 24 infants (5%) weighed ≤500g (Table 1.2), of whom three were ≤401g 
(the lowest birthweight recorded was 350g). The majority of infants (31%; n=166) were born with 
a birthweight >1250g of which 19 infants had a birthweight >1500g. Data for the years 2014 to 
2017 are also included in Table 1.2. 
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2. Infant Characteristics
In 2018, ROI and VON groups were relatively 
similar with respect to the proportion of infants 
who received prenatal care, antenatal steroids 
and who were born by C-Section (Table 2.1). 
Differences between Ireland and the VON 
network were evident with respect to Maternal 
Chorioamnionitis, Antenatal Steroids, Antenatal 
Magnesium Sulphate, Multiple Gestation and 
Major Congenital Anomaly (MCA) (all of which 
were reported in a higher proportion of ROI 
infants compared to VON infants) and Maternal 
Hypertension (which was reported in a lower 
proportion of ROI infants). 
Table 2.1: Infant characteristics in the Republic of Ireland and VON, 2018. 
Characteristic
Republic of Ireland VON
Cases N % Median % Q1 % Q3 %
Male 283 537 53 51 46 56
Prenatal Care 518 535 97 97 94 100
Chorioamnionitis* 94 537 18 8 3 17
Maternal Hypertension 115 526 22 33 25 41
Antenatal Steroids 472 532 89 86 77 91
C-Section 391 537 73 73 67 80
Antenatal Magnesium Sulphate 366 531 69 62 43 75
Multiple Gestation 162 536 30 21 17 31
Major Congenital Anomaly (MCA)* 45 536 8 4 0 8
Small for Gestational Age (SGA) 115 535 22 24 19 31
Note: N represents the total number of very low birth weight babies (VLBW) in Ireland. For Ireland the % is based on the 
cases as the numerator and the total, N, as the denominator. For VON the total number of VLBW infants with information 
available on each characteristic reported ranged between 61,331 and 62,097. The VON reports the Median % based on the 
units that submit data, as outlined in the methods section. Half of the units report a % lower than the median, one quarter of 
the units report a % lower than Q1 and three quarters of the units report a % lower than Q3. 
*At least 75% of all VON units had lower levels of chorioamnionitis & MCA than reported for ROI.
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3. Survival
Table 3.1: Survival of ROI and VON infants, including those with congenital anomalies, 2018. 
Measure Year
Republic of Ireland VON
Cases N % Median % Q1 % Q2 %
Survival*
2014 492 600 82 87 82 91
2015 525 622 84 87 82 92
2016 496 593 84 87 83 92
2017 501 611 82 86 83 92





2014 318 600 53 59 50 69
2015 337 622 54 59 50 69
2016 333 593 56 59 51 70
2017 343 605 57 59 50 70
2018 284 527 54 61 51 71
Note: N represents the total number of very low birth weight babies in ROI. For ROI the % is based on the cases as the numerator 
and the total, N, as the denominator. For VON the total number of VLBW infants with information on survival and survival without 
morbidities was 61,489 and 61, 294 respectively. The VON reports the Median % based on the units that submit data, as outlined 
in the methods section. Half of the units report a % lower than the median, one quarter of the units report a % lower than Q1 and 
three quarters report a % lower than Q3. At least 3 quarters of the VON units had higher survival than reported in ROI. 
* Indicates whether the infant survived to discharge home or first birthday. 
**Denotes severe IVH, chronic lung disease in infants <33 weeks gestation, NEC, pneumothorax, any late infection or cystic PVL.
In 2018, a total of 82% (n=435) of VLBW infants 
born in the ROI survived to discharge home or 
first birthday. At least 75% of the VON units had 
higher survival than reported in ROI. (Table 3.1). 
Over the five-year period, 2014-2018, the range 
for the proportion surviving in Ireland was 
82-84%. The median survival for VON over the 
same time period was 86-88%.
In 2018, 54% of infants survived without the 
specified morbidities of severe IVH, chronic 
lung disease in the group of infants with <33 
weeks of gestation, NEC, pneumothorax, any 
late infection or cystic PVL. This figure is in line 
with previous years. While, this rate was lower 
than the VON Median of 61%, it was within the 
interquartile range of 51-71% (Table 3.1). 
Survival to discharge of VLBW infants by birth weight and gestational age is reported in Tables 3.2 and 
3.3 respectively for the years 2014 through to 2018. 
In line with previous years, there was a general trend of increased survival to discharge with increasing 
birth weight in 2018 (Table 3.2). In 2018, two infants born less than 501g survived (N=23, 9%). 
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Survival to discharge increased with advancing 
gestational age in 2018 until 30 weeks gestation, 
above which there was a slight variation away 
from this pattern, consistent with previous years 
(Table 3.3). In 2018, all the infants born at >32 
weeks and who did not survive, had an MCA. 
At 23 weeks’ gestation, nine infants (33% of 27 
infants) survived to discharge in 2018, lower than 
the figure of 47% for 2017. The gradual increase 
in the percentage survival for this gestational age 
year on year since 2014 was not noted in 2018. 
Table 3.3: Survival to discharge by gestational age breakdown for ROI infants, including those with congenital 
anomalies, 2014-2018. 













<22 weeks 0/2 (0%) 0/2 (0%) 0/2 (0%) 0/6 (0%) 0/5 (0%)
22 weeks 0/18 (0%) 0/16 (0%) 0/19 (0%) 0/16 (0%) 0/12 (0%)
23 weeks 4/21 (19%) 9/30 (30%) 10/27 (37%) 7/15 (47%) 9/27 (33%)
24 weeks 18/36 (50%) 22/34 (65%) 25/45 (56%) 21/37 (56%) 20/39 (51%)
25 weeks 25/35 (71%) 33/43 (77%) 39/50 (78%) 27/50 (54%) 32*/41 (78%)
26 weeks 28/43 (65%) 30/37 (81%) 34/39 (87%) 31/39 (79%) 50*/54 (93%)
27 weeks 54/57 (95%) 40/46 (87%) 47/49 (96%) 60/69 (87%) 46*/52 (88%)
28 weeks 75/83 (90%) 82/90 (91%) 77/83 (93%) 83/88 (94%) 65*/69 (94%)
29 weeks 89/95 (94%) 94/99 (95%) 80/85 (94%) 74/83 (89%) 70/75 (93%)
30 weeks 68/71 (96%) 65/65 (100%) 62/66 (94%) 84/87 (97%) 51/53 (96%)
31 weeks 44/49 (90%) 64/68 (94%) 49/50 (98%) 52/54 (96%) 31/34 (91%)
32 weeks 36/39 (92%) 35/37 (95%) 34/36 (94%) 28/31 (90%) 36/39 (92%)
>32 weeks 46/48 (96%) 51/55 (93%) 39/42 (93%) 34/37 (92%) 25*/30 (83%)
Total 487/597 (82%) 525/622 (84%) 496/593 (84%) 501/612 (82%) 435/530 (82%)
*Seven infants in 2018 did not have information on survival to discharge: one infant born at 25 weeks; three infants born at 26 
weeks; one infant born at 27 weeks; one infant born at 28 weeks and one infant born at 35 weeks. Hence the denominator is 530. 
Table 3.2: Survival to discharge by birth weight for ROI infants, including those with congenital anomalies, 2014-2018.
Number of survivors/Number of liveborn infants (%)










<501g 2/26 (8%) 4/23 (17%) 6/21 (29%) 3/23 (13%) 2/23* (9%)
501-600g 9/32 (28%) 19/37 (51%) 12/33 (36%) 16/39 (41%) 19/32* (59%)
601-700g 24/36 (67%) 29/45 (64%) 32/51 (63%) 23/33 (70%) 24/42 (57%)
701-800g 27/37 (73%) 26/37 (70%) 35/49 (71%) 29/43 (67%) 27/39* (69%)
801-900g 29/37 (78%) 33/40 (83%) 40/47 (85%) 35/47 (74%) 37/44 (84%)
901-1000g 51/58 (88%) 34/39 (87%) 45/49 (92%) 48/53 (91%) 51/54 (94%)
1001-1100g 47/54 (87%) 54/59 (92%) 51/54 (94%) 55/64 (86%) 41/46 (89%)
1101-1200g 60/64 (94%) 58/64 (91%) 62/67 (93%) 60/64 (94%) 47/50 (94%)
1201-1300g 77/81 (95%) 63/67 (94%) 61/63 (97%) 65/69 (94%) 51/53* (96%)
1301-1400g 67/72 (93%) 84/87 (97%) 62/64 (97%) 74/80 (93%) 56/60 (93%)
>1400g 94/99 (95%) 121/124 (98%) 90/95 (95%) 93/97 (96%) 80/87 (92%)
Total 487/596* (82%) 525/622 (84%) 496/593 (84%) 501/612 (82%) 435/530 (82%)
*One infant in 2014 did not have a recorded birth weight and therefore the denominator was 596. *Seven infants in 2018 did not 
have information on survival to discharge: one infant <501g; one infant 501-600g; three infants 701-800g; two infants 1201-1300g. 
Hence the denominator is 530. 
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As shown in table 3.4, the proportion of infants 
surviving discharge without specified morbidities 
increased with advancing gestational ages. The 
percentage of infants surviving without specified 
morbidities has also marginally increased over 
the past four years, although a slight decrease 
was recorded for 2018. None of the infants born 
≤ 23 weeks gestation survived without specified 
morbidities. 
Table 3.4: Survival without specified morbidities1 of infants according to gestational age at birth of ROI infants 
reported to VON, 2014-2018.













≤ 22 weeks 0/20 (0%) 0/18 (0%) 0/21 (0%) 0/22 (0%) 0/15 (0%)
23 weeks 0/21 (0%) 1/30 (3%) 2/27 (7%) 1/15 (7%) 0/27 (0%)
24-27 weeks 45/169 (27%) 40/160 (25%) 59/182 (32%) 57/190 (30%) 69/186 (37%)
28-31 weeks 193/297 (65%) 213/322 (66%) 202/284 (71%) 226/310 (73%) 158/230 (69%)
≥32 weeks 73/87 (84%) 83/92 (90%) 70/78 (90%) 59/68 (87%) 57/69 (83%)
Total 311/594* (52%) 337/622 (54%) 333/592* (56%) 343/605* (57%) 284/527* (54%)
Note: Figures include infants with congenital anomalies. 
1Specified Morbidities include severe IVH, chronic lung disease in infants <33 weeks gestation, NEC, pneumothorax, any late 
infection and/or cystic PVL. 
*Data on survival without specified morbidities:
Unknown for 3 infants in 2014: 2 infants born at 24-27 weeks gestation and 1 infant born at 28-31 weeks; 
Unknown for 1 infant born in 2016: infant born at 24-27 weeks gestation; 
Unknown for 7 infant born in 2017: 5 infants born at 24-27 weeks gestation and 2 infants born at 28-31 weeks; Unknown for 
7 infant born in 2018: 2 infants born at 22 weeks, 5 infants born at 24-27 weeks gestation, 2 infants born at 28-31 weeks and 1 
born at >32 weeks. 
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4. Key Performance Indicators
VON reports on a number of Key Performance 
Indicators (KPIs). This allows the ROI to compare 
its outcomes to VON as a whole. It is important 
for benchmarking performance in the ROI in 
addition to identifying areas of strengths and 
areas where continuous improvements could/
should be made. 
The KPIs are listed below and relevant definitions 
are outlined above in the Definitions and 
Terminology section:
1. Mortality
2. Mortality Excluding Early Deaths 
3. Death or Morbidity 
4. CLD
5. Pneumothorax
6. Late Bacterial Infection
7. Coagulase Negative Infection
8. Nosocomial Infection
9. Fungal Infection
10. Any Late Infection 






For each KPI, the number and percentage of ROI 
infants that experienced the outcome in 2018 is 
reported and illustrated in the following charts 
alongside the equivalent figures for all infants 
recorded in the VON database. The reporting of 
the KPIs in numbers and percentages for ROI and 
VON infants is provided for descriptive purposes. 
Observed differences in KPIs may be related 
to the medical care provided but may also be 
due to differences between the ROI and VON 
infant populations. Robust comparison of KPIs 
between the ROI and VON requires that pertinent 
differences between the infant populations are 
taken into account. This is done through the 
calculation of standardised mortality/morbidity 
Ratios (SMRs).
Standard Mortality/Morbidity Ratios 
(SMRs)
Based on all VON data for infants with birth 
weights 501-1500g, our VON colleagues use 
multivariable logistic regression models for each 
KPI to quantify the risk of the outcome associated 
with each of the following infant characteristics: 
gestational age, SGA, multiple gestation, Apgar 
score at 1 min, gender, vaginal birth, location 
(inborn or outborn) and birth defect severity. 
Coefficients from these regression models were 
provided to the NPEC for use in the calculation of 
SMRs for each KPI.
SMRs were calculated for ROI babies with birth 
weights 501-1500g and with complete data for the 
KPI in question and the infant characteristics used 
in the regression models.
For each KPI, the coefficients were applied to the 
data of these eligible ROI infants to estimate the 
risk of the outcome for each infant. Summing these 
individual risk estimates gives the total number 
of infants that would be expected to experience 
the outcome, i.e. the expected number taking into 
account the risk profile of the ROI infants.
To obtain the SMR for each KPI, the number of 
eligible ROI infants that actually experienced the 
outcome, i.e. the observed number of cases, was 
divided by the expected number of cases (SMR = 
Observed/Expected).
SMR values equal or close to one indicate 
that there is little or no difference between 
the observed and expected number of infants 
that experienced the outcome, i.e. the number 
observed was to be expected given the risk profile 
of the ROI infant population. SMRs greater than 
one indicate that more infants experienced the 
outcome than expected given the risk profile of 
the ROI infants. SMRs less than one indicate that 
fewer cases were observed among ROI infants 
than expected.
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A 95% confidence interval was calculated for each 
SMR in order to facilitate making inferences about 
whether the SMRs indicated if the difference 
between observed and expected was statistically 
significant. If the 95% confidence interval did not 
include the value one, it may be inferred that the 
difference between the numbers of observed and 
expected cases was statistically significant, i.e. 
there were more or fewer cases among the ROI 
infants than expected given their risk profile.
For each KPI, the absolute difference between 
the observed and expected number of cases is 
reported and the 95% confidence interval for this 
difference is also reported in order to provide 
statements in terms of the actual number of 
infants affected.
SMRs for Key Performance indicators in 
2018 
Table 4.1 displays Standardised Mortality/
Morbidity Ratios (SMR = Observed/Expected), 
the lower and upper bounds of its 95% confidence 
interval, the difference between the Observed 
and Expected number of cases and the lower and 
upper bound of the 95% confidence interval for 
this difference.
Of all the KPIs measured, Pneumothorax recorded 
the highest SMR (1.56; CI 1.13, 1.98), as it did in 2017. 
Twelve more infants experienced this outcome in 
ROI than would have been expected considering 
their risk profile. The increased number of cases 
was greater, at 16 infants, in 2017. Additionally, the 
SMR data shows that ROI infants were less often 
than expected diagnosed with severe retinopathy 
of prematurity (SMR 0.39; CI 0, 0.83).
Table 4.1: Risk Adjusted Standardised Mortality/Morbidity Ratios for Key Performance Indicators, Republic of 
Ireland, 2018. 
Outcome O E SMR (95% CI) O-E (95% CI)
Mortality 71 64 1.11 (0.87, 1.36) 7 (-8, 23)
Mortality excluding early death 52 46 1.12 (0.83, 1.41) 6 (-8, 19)
Death or Morbidity 216 214 1.01 (0.88, 1.15) 2 (-26, 31)
Chronic Lung Disease 95 98 0.97 (0.77, 1.17) -3 (-22, 17)
Pneumothorax* 33 21 1.56 (1.13, 1.98) 12 (3, 21)
Late Bacterial Infection 34 39 0.88 (0.56, 1.20) -5 (-17, 8)
Coagulase Negative Infection 28 23 1.20 (0.80, 1.61) 5 (-5, 14)
Nosocomial Infection 53 54 0.97 (0.71, 1.24) -1 (-16, 13)
Fungal Infection 1 4 0.23 (0.00, 1.17) -3 (-7, 1)
Any Late Infection 54 56 0.96 (0.70, 1.22) -2 (-17, 12)
Intraventricular Haemorrhage 112 113 0.99 (0.80, 1.17) -1 (-22, 19)
Severe Intraventricular Haemorrhage 32 35 0.90 (0.57, 1.23) -3 (-15, 8)
Retinopathy of Prematurity 95 112 0.85 (0.67, 1.04) -17 (-37, 4)
Severe Retinopathy of Prematurity* 8 20 0.39 (0.00, 0.83) -12 (-21, -4)
Cystic Periventricular Leukomalacia 11 13 0.88 (0.32, 1.43) -2 (-8, 5)
Necrotising Enterocolitis 31 25 1.22 (0.83, 1.61) 6 (-4, 16)
“O” refers to the number of observed cases with the outcome and “E” to the expected number with the outcome of ROI 
infants with birth weights 501-1500g. 95% confidence intervals (CIs) are provided for the SMR and the difference in observed 
and expected cases. 
*Indicates a statistically significant difference.
21< Contents
Mortality in infants with birth weights 501-
1500g
Amongst ROI infants with birth weights 501-
1500g, there were 71 deaths observed whereas 
the expected number based on the risk profile 
of the infants in the ROI population was 64 
(Table 4.1). The SMR was 1.11 (95% CI: 0.87, 1.36). 
This SMR is consistent with that reported for 
previous years with SMR of 1.27, 1.15, 1.10 and 1.19 
for 2014, 2015, 2016 and 2017, respectively (Table 
4.3). In absolute numbers there were seven 
more deaths than expected in 2018 whereas the 
excess number in 2014-2017 was in the range 8-21 
deaths. 
The SMR for mortality was almost unchanged 
when calculated after excluding early deaths 
(SMR=1.12; 95% CI: 0.83, 1.41). There were 52 
observed deaths and 46 expected deaths 
based on the risk profile of infants in the ROI 
(Table 4.1). Thus, there were six more observed 
deaths (excluding early deaths) than the number 
expected, a difference that was not statistically 
significant (95% CI -9, 19).
Death or Morbidity in infants with birth weights 
501-1500g
The risk of the composite outcome of death or 
morbidity in 2018 showed no evidence of being 
higher or lower than expected (SMR=1.01; 95% 
CI: 0.88, 1.15). Amongst ROI infants with birth 
weights 501-1500g, there were 216 observed 
cases of death or morbidity, whereas the 
expected number based on the risk profile of the 
infants in the Irish population was 214 (Table 4.1). 
Thus, there were just two more cases of death 
or morbidity in the ROI than expected, a finding 
which was not statistically significant (95% CI: 
-26, 31).
CLD in infants with birth weights 501-1500g
There were 95 observed cases of CLD amongst 
ROI infants with birth weights 501-1500g whereas 
the expected number based on the risk profile 
of infants in the Irish population was similar at 
98 (Table 4.1). The SMR was 0.97 (95% CI: 0.77, 
1.17), reinforcing that the number of observed 
cases was in line with the expected number. In 
absolute numbers there were three fewer cases 
of CLD than expected, which not a statistically 
significant difference (95% CI: -22, 17).
Pneumothorax in infants with birth weights 501-
1500g
There were 33 observed cases of pneumothorax 
amongst ROI infants with birth weights 501-
1500g whereas the expected number based 
on the risk profile of the infants in the Irish 
population was 21 (Table 4.1). The SMR was 1.56 
(95% CI: 1.13, 1.98), indicating that the number 
of observed cases was 56% higher than the 
expected number. In absolute numbers there 
were 12 more cases of pneumothorax (95% CI: 
3, 21) than expected, a statistically significant 
difference, and similar to what was observed in 
2017. To better understand the elevated risk of 
pneumothorax amongst ROI infants, further in-
depth analysis using the data accumulated over 
multiple years will be carried out.
Infections: late bacterial infection, coagulase 
negative infection, nosocomial infection, fungal 
infection and any late infection. 
Observed and expected risk were similar for the 
KPIs related to infection, as detailed in Table 4.1 
and illustrated in Figure 4.1.
Amongst ROI infants with birth weights 501-
1500g, there were 34 observed compared to 
39 expected cases of late bacterial infection 
(SMR=0.88, 95% CI: 0.56, 1.20). There were 28 
observed compared to 23 expected cases of 
coagulase negative infection (SMR=1.20, 95% CI: 
0.80, 1.61). The observed and expected number 
of cases were almost identical for nosocomial 
infection (SMR=0.97, 95% CI: 0.71, 1.24) and any 
late infection (SMR=0.96; 95% CI: 0.70, 1.22).
Intraventricular Haemorrhage (IVH) and severe 
IVH in infants with birth weights 501-1500g
IVH was observed in 112 ROI infants weighing 
501-1500g at birth, almost identical to the 113 
cases expected based on the infants’ risk profile 
(SMR=0.99, 95% CI: 0.80, 1.17; Table 4.1). In 
absolute numbers, there was one case fewer than 
expected, which was not statistically significant 
(95% CI: -22, 19).
For severe IVH, there were 32 observed cases 
compared to an expected number of 35 cases 
(SMR=0.90, 95% CI: 0.57, 1.23). This difference 
of three cases fewer than expected was not 
statistically significant (95% CI: -15, 8; Table 4.1).
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Figure 4.1: Comparison of infections in ROI and VON infants, 2018. 
Note: Dark blue bar represents the interquartile range for units reporting to the VON. The dark blue horizontal marker indicates 
the median of units reporting to the VON.
ROP in infants with birth weights 501-1500g
Considering ROI infants born weighing 501-1500g 
for whom risk adjustment was performed, there 
were 95 observed cases of ROP compared to an 
expected number of 112 cases (Table 4.1). Thus, 
the observed number equated to 85% of the 
expected number, but this was not a statistically 
significant difference (SMR=0.85, 95% CI: 0.67, 
1.04). In absolute numbers, there were 17 fewer 
cases of ROP than expected (95% CI: -37, 4).
The difference was more marked with regard to 
severe ROP. There were eight observed cases 
compared to an expected number of 20 cases 
based on the risk profile of infants in the ROI 
population. Thus, the observed number equated 
to less than half of the expected number, 
which was a statistically significant difference 
(SMR=0.39, 95% CI: 0, 0.83). In absolute terms, 
there were 12 fewer cases of severe ROP cases 
than expected (95% CI: -21, -4; Table 4.1).
Cystic PVL in infants with birth weights 501-
1500g
Considering ROI infants with 501-1500g birth 
weights, there were 11 observed cases of cystic 
PVL whereas the number expected based on 
their risk profile was 13 (Table 4.1). Thus, the 
observed number was close to the expected 
(SMR=0.88, 95% CI: 0.32, 1.43). In absolute 
numbers the two fewer cases observed did not 
represent a statistically significant difference 
from the expected number (95% CI: -8, 5).
NEC in infants with birth weights 501-1500g
Amongst the ROI infants born weighing 501-
1500g there were 31 observed cases of NEC and 
an expected number of 25 cases (SMR=1.22, 95% 
CI: 0.83, 1.61; Table 4.1). This was not a statistically 
significant difference (95% CI: -4, 16).
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Table 4.2: Distribution of each Key Performance Indicator according to gestational age categories of VLBW infants 
born in the ROI, 2018. 
Outcomes 24-27 weeks 28-31 weeks ≥32 weeks Total
Mortality 34 (19%) 10 (5%) 8 (12%) 52 (11%)
Mortality excluding early death 31 (17%) 7 (3%) 3 (4%) 41 (9%)
Death or Morbidity 112 (62%) 65 (31%) 12 (17%) 189 (41%)
Chronic Lung Disease 54 (29%) 26 (12%) 6 (9%) 86 (18%)
Pneumothorax 18 (10%) 13 (6%) 1 (2%) 32 (7%)
Late Bacterial Infection 19 (10%) 7 (3%) 1 (1%) 27 (6%)
Coagulase Negative Infection 17 (9%) 5 (2%) 0 (0%) 22 (5%)
Nosocomial Infection 33 (18%) 10 (5%) 1 (1%) 44 (9%)
Fungal Infection 1 (1%) 0 (0%) 0 (0%) 1 (0%)
Any Late Infection 34 (18%) 10 (5%) 1 (1%) 45 (10%)
Intraventricular Haemorrhage 70 (38%) 32 (15%) 4 (6%) 106 (23%)
Severe Intraventricular Haemorrhage 22 (12%) 7 (3%) 0 (0%) 29 (6%)
Retinopathy of Prematurity 68 (37%) 16 (8%) 5 (7%) 89 (19%)
Severe Retinopathy of Prematurity 8 (4%) 0 (0%) 0 (0%) 8 (2%)
Cystic Periventricular Leukomalacia 5 (3%) 6 (3%) 0 (0%) 11 (2%)
Necrotising Enterocolitis 20 (11%) 5 (2%) 1 (1%) 26 (6%)
Note: Association between outcomes (KPIs) and gestational age was significant at P-value <0.05, except for fungal infection and 
cystic periventricular leukomalacia.
Key Performance Indicators and Gestational Age
The proportion and number of infants recording each of the KPIs measured according to their 
gestational age, for those born after 24 weeks of gestation, is outlined in table 4.2. A statistically 
significant decrease in all KPIs was observed with higher gestational ages, with the exception 
of fungal infection and cystic periventricular leukomalacia due to limited numbers. This denotes 
a lower percentage of mortality, morbidity and specific outcomes (as measured in the KPIs) in 
infants born with higher gestational ages.
Time trends in relative risk
SMRs for each KPI have been calculated for ROI 
infants with birth weights 501-1500g for four 
years, 2014 through to 2018. These SMRs enable 
an assessment of whether the risk of a KPI has 
changed over time. For each KPI, Table 4.3 
displays the SMR and its 95% confidence interval 
for each year.
There is evidence of improvement with respect to 
several KPIs. In the first two years with national 
data, the observed risk of death or specified 
morbidity was 14-16% higher than expected, a 
statistically significant difference each year. The 
observed and expected risk were almost identical 
in each of the next three years. 
A similar trend was observed between 2014-2015 
and 2016-2018 for coagulase negative infection 
and nosocomial infection. The observed excess 
risk of coagulase negative infection was largely 
confined to 2014 and 2015 when 84% and 60% 
more cases than expected were observed. The 
excess risk of 13-20% reported during 2016-
2018 was not statistically significant. Similarly, 
nosocomial infection was 30% and 43% more 
common than expected in 2014 and 2015, 
respectively (a statistically significant difference). 
The excess risk reduced to 17% in 2016 and 
reduced further in 2017 and 2018 and is no longer 
statistically significant. 
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Table 4.3: Standardised Mortality/Morbidity Ratios for Key Performance Indicators, Republic of Ireland, 2014-2018.
Outcome
2014 2015 2016 2017 2018
SMR (95% CI) SMR (95% CI) SMR (95% CI) SMR (95% CI) SMR (95% CI)
Mortality 1.27 (1.03, 1.51) 1.15 (0.91, 1.39) 1.10 (0.87, 1.34) 1.19 (0.96, 1.42) 1.11 (0.87, 1.36)
Mortality excluding 
early death
1.23 (0.92, 1.54) 1.01 (0.70, 1.31) 1.12 (0.84, 1.41) 1.20 (0.93, 1.48) 1.12  (0.83, 1.41)
Death or Morbidity 1.14 (1.01, 1.27) 1.16 (1.03, 1.29) 1.02 (0.89, 1.15) 1.01 (0.89, 1.14) 1.01 (0.88, 1.15)
Chronic Lung 
Disease
1.08 (0.88, 1.28) 1.07 (0.87, 1.27) 0.95 (0.75, 1.15) 1.12 (0.93, 1.31) 0.97  (0.77, 1.17)
Pneumothorax 1.67 (1.25, 2.10) 1.80 (1.37, 2.24) 1.40 (0.98, 1.82) 1.69 (1.29, 2.1) 1.56  (1.13, 1.98)
Late Bacterial 
Infection
0.90 (0.58, 1.22) 0.97 (0.68, 1.26) 1.12 (0.81, 1.43) 0.89 (0.59, 1.18) 0.88  (0.56, 1.20)
Coagulase Negative 
Infection
1.84 (1.45, 2.23) 1.60 (1.22, 1.99) 1.13 (0.74, 1.52) 1.16 (0.8, 1.53) 1.20 (0.80, 1.61)
Nosocomial 
Infection
1.30 (1.04, 1.57) 1.43 (1.17, 1.69) 1.17 (0.91, 1.43) 1.04 (0.8, 1.29) 0.97  (0.71, 1.24)
Fungal Infection 0.55 (0.0, 1.57) 0.70 (0.0, 1.65) 0.25 (0.73, 1.24) 0.84 (0.06, 1.74) 0.23 (0, 1.17)
Any Late Infection 1.26 (1.00, 1.52) 1.44 (1.18, 1.7) 1.13 (0.88, 1.39) 1.03 (0.78, 1.27) 0.96 (0.70, 1.22)
Intraventricular 
Haemorrhage




1.22 (0.85, 1.58) 1.15 (0.80, 1.51) 1.32 (0.98, 1.67) 0.90 (0.59, 1.22) 0.90 (0.57, 1.23)
Retinopathy of 
Prematurity
0.51 (0.33, 0.70) 0.71 (0.53, 0.89) 0.62 (0.45, 0.8) 0.72 (0.54, 0.89) 0.85  (0.67, 1.04)
Severe Retinopathy 
of Prematurity




0.32 (0.0, 0.87) 1.26 (0.71, 1.82) 0.56 (0.0, 1.11) 0.66 (0.15, 1.16) 0.88 (0.32, 1.43)
Necrotising 
Enterocolitis
1.21 (0.84, 1.59) 1.47 (1.08, 1.86) 1.39 (1.01, 1.78) 1.22 (0.86, 1.59) 1.22  (0.83, 1.61)
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5. Survival according to designated category of neonatal unit 
There are 19 neonatal centres in the ROI that 
are affiliated with an Obstetric Service. These 
are classified as tertiary, regional or peripheral 
neonatal centre based on the number of births 
per annum in the affiliated obstetric centre 
and the level of neonatal consultant cover in 
the neonatal centre. There are four designated 
tertiary neonatal centres, four designated 
regional neonatal centres and eleven designated 
peripheral neonatal centres (Table 5.1). Each 
of the tertiary centres delivered more than 
7,000 births per annum and all provide 24-hour 
consultant neonatology cover. The regional 
centres have dedicated neonatal intensive care 
units (NICUs) in their centres but deliver less 
than 7,000 infants yearly or do not have 24-hour 
consultant neonatology cover. In 2018, one of 
these four centres delivered between 4,000-
5,000 births per annum; one centre delivered 
between 3,000-4,000 births per annum; one 
centre delivered between 2,000-3,000 births per 
annum and the fourth centre delivered less than 
2,000 births per annum when births weighing 
500g or more are counted (Table 5.1). Peripheral 
centres do not have dedicated NICUs nor do they 
have dedicated consultant neonatology cover 
but they do have designated areas for newborn 
infants namely Special Care Baby Units (SCBUs). 
In 2018, all peripheral centre delivered less than 
2,000 births per annum. 
Table 5.1: Number of live births and stillbirths weighing greater than or equal to 500g in maternity 
centres in 2018. 
Hospital Number of births 
Designated Tertiary Neonatal Centres
National Maternity Hospital > 7,000
Coombe Women & Infants University Hospital > 7,000
Rotunda Hospital > 7,000
Cork University Maternity Hospital > 7,000
Designated Regional Neonatal Centres
University Maternity Hospital Limerick 4,000-5,000
Our Lady of Lourdes Hospital Drogheda 3,000-4,000
Galway University Hospital 2,000-3,000
University Hospital Waterford < 2,000
Designated Peripheral Neonatal Centres
Midland Regional Hospital Mullingar < 2,000
Portiuncula Hospital Ballinasloe < 2,000
Wexford General Hospital < 2,000
Midland Regional Hospital Portlaoise < 2,000
St Luke’s Hospital Kilkenny < 2,000
Cavan General Hospital < 2,000
Mayo University Hospital < 2,000
Letterkenny University Hospital < 2,000
University Hospital Kerry < 2,000
Sligo University Hospital < 2,000
South Tipperary General Hospital < 2,000
Source: Annual Clinical Reports of hospitals and hospital groups; and personal communication with individual.
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All the 537 VLBW infants reported to VON 
in 2018, had birth location data suitable for 
analysis of survival outcome based on the 
designated category of neonatal centre in 
which they were born (i.e. tertiary, regional or 
peripheral). 
In 2018, 393 infants (73%) were born in one 
of the four tertiary neonatal centres, 101 (19%) 
were born in one of the four regional neonatal 
centres and the remaining 43 infants (8%) were 
born in one of eleven peripheral centres (Table 
5.2). This compares to 71% (n=112), 18% (n=112) 
and 11% (n=67) born in tertiary, regional and 
peripheral centres in 2017.(2) 
Table 5.2 also shows that of all infants born 
between 23 and 27 weeks gestation (n=218), 
174 (80%) were born in a tertiary neonatal 
centre, 21 (10%) were born in a regional 
neonatal centre and 23 (11%) were born in a 
peripheral centre in 2018. This compares to 
167 (80%) in a total 210 infants born at this 
gestation in tertiary centres in 2017 and 85% 
(n=178) in 2016. The current Model of Care 
for Neonatal Services in Ireland recommends 
that infants born <28 weeks should ideally be 
delivered at a tertiary neonatal centre.(3)
Resuscitation in the delivery room (defined as 
the administration of positive pressure breaths 
via a face mask and/or an endotracheal tube) 
was provided to a total of 385 (72%) infants in 
2018 (Table 5.2) compared to 68% of infants 
in 2017. Overall, 71% of those born in a tertiary 
centre, 72% of those born in a regional centre 
and 79% of those born in a peripheral centre 
were resuscitated in 2018 (Table 5.2). This 
compares to figures of 73%, 60% and 51% 
respectively for the previous year.2 























































*No information available on the survival outcome of seven babies born in tertiary centres.
Of the 385 infants who received resuscitation 
in the delivery room, three died in the delivery 
room and 382 survived to admission to a 
NICU/SCBU (Figure 5.1). The gestational age 
category of infants resuscitated according to 
the category of neonatal centre where these 
infants were born, is shown in table 5.3. Of the 
385 infants who received resuscitation, 314 
(82%) survived to discharge (Figure 5.1). The 
remaining 71 (18%) infants died, three of whom 
died in the delivery room. Survival outcome 
was not known for seven infants. 
The 2018 report on mortality risk among VLBW 
infants between 2014-2016, recommended 
that all infants born at 23 weeks gestation, if 
presenting in a favourable condition, should be 
offered resuscitation.4 A total of 89% of infants 
born at 23 weeks gestation were resuscitated at 
birth compared to 87% in 2017 and 74% in 2016. 
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Admission to NICU/SCBU was recorded for 507 
infants, of which 370 (94%) were born at tertiary 
centres, 97 (96%) at regional centres and 40 
(93%) at peripheral centres (Table 5.2). These 
numbers included infants who were transferred 
out of the birth hospital and to another neonatal 
and/or paediatric centre within 48 hours of 
birth. A total of 30 (6%) of the 537 infants were 
transferred and the majority of these infants 
(n=23; 77% of the total infants transferred) were 
born in peripheral centres. The two infants born in 
a tertiary centre who were transferred out within 
48 hours of birth were transferred to a paediatric 
hospital in Ireland. The five infants from regional 
centres and 20 infants from peripheral centres 
were all transferred out to tertiary neonatal 
centres. Three of the infants born in peripheral 
centres were transferred, within 48 hours of birth, 
to a regional centre. 
Table 5.4 outlines the gestational age category of 
the infants born in each of the three categories of 
neonatal centres with reference to those infants 
who required transfer. As shown in the table, 
the majority of transfers from peripheral centres 
related to infants born between 24-27 and 28-31 
weeks gestation whereas the two transfers that 
occurred from tertiary centres related to infants 
with a gestation birth between 28-31 weeks and 
≥32 weeks.
Table 5.4: Number of infants born in each category of neonatal centre, and number transferred within 48 hours, 
according to gestational age, 2018, n=537. 
Gestational Age
TERTIARY 
No. transferred  
within 48 hours/  
No. born (%)
REGIONAL 
No. transferred  
within 48 hours/  
No. born (%)
PERIPHERAL 
No. transferred  
within 48 hours/  
No. born (%)
≤ 22 weeks 0/14 (0%) 0/2 (0%) 0/1 (0%)
23 weeks 0/24 (0%) 0/2 (0%) 0/1 (0%)
24-27 weeks 0/150 (0%) 3/19 (16%) 11/22 (50%)
28-31 weeks 1/152 (1%) 2/63 (3%) 12/17 (71%)
≥32 weeks 1/53 (2%) 0/15 (0%) 0/2 (0%)
Total 2/393 (1%) 5/101 (5%) 23/43 (53%)
The overall crude survival rate for ROI infants in 2018 was 82% (n=435/530): the highest rate of 
survival occurred in the regional centres at 87%, followed by the peripheral centres (86%) and the 
tertiary centres at 80% (Figure 5.1 and Table 5.2). In 2017, regional centres had a survival rate of 
88%, and tertiary and peripheral centres had a rate of 81% and 79% respectively.2 
Table 5.3: Number of infants born in each category of neonatal centre who were administrated resuscitation 













born (% of liveborn)
Total
≤ 22 weeks 1/14 (7%) 0/2 (0%) 0/1 (0%) 1/17 (6%)
23 weeks 22/24 (92%) 1/2 (50%) 1/1 (100%) 24/27 (89%)
24-27 weeks 134/150 (89%) 18/19 (95%) 19/22 (86%) 171/191 (90%)
28-31 weeks 102/152 (67%) 46/63 (73%) 13/17 (76%) 161/232 (69%)
≥32 weeks 19/53 (36%) 8/15 (53%) 1/2 (50%) 28/70 (40%)
Total 278/393 (71%) 73/101 (72%) 34/43 (79%) 385/537 (72%)

























































































Figure 5.1: Flow chart illustrating survival outcomes of all VLBW infants born, according to designated 





Survival of infants born at 22 and 23 
weeks gestation according to category 
of neonatal centre
Overall, 44 infants were born <24 weeks 
gestation, of which 38 (86%) were born in 
tertiary neonatal centres, four (9%) in regional 
centres and the remaining two (5%) in one of the 
eleven peripheral centres. 
Infants born at ≤ 22 weeks gestation in ROI 
Of the 17 infants born at ≤ 22 weeks gestation 
in Ireland in 2018, 1 infant (6%) was born in a 
peripheral centre, 2 (12%) in regional centres and 
14 (82%) infants were born in tertiary centres.
One infant born in a tertiary centre was 
resuscitated in the delivery room (Table 5.5), this 
infant was admitted to NICU although they did 
not survive to discharge. 
The remaining 16 infants born at ≤ 22 weeks 
gestation died in the delivery room, none of 
these infants had an MCA. 











Liveborn infants 14 2 1 17
Received resuscitation in the delivery room 1 (7%) 0 (0%) 0 (0%) 1 (6%)
Admitted to a NICU/SCBU 1 (7%) 0 (0%) 0 (0%) 1 (6%)
Transferred to another neonatal centre within 
48 hours of birth 
0 (0%) 0 (0%) 0 (0%) 0 (0%)
Survived to discharge 0 (0%) 0 (0%) 0 (0%) 0 (0%)
Note: Percentage from the total liveborn infants in each category. 
Table 5.6 outlines the trend in survival and provision of resuscitation to ROI infants born at ≤22 weeks 
gestation over the past 5 years. No infant born ≤22 weeks gestation survived to discharge since 2014, 
the inception of this report. 











Liveborn infants 20 18 21 22 17 
Received resuscitation in the delivery room 1 (5%) 0 1 (5%) 2 (9%) 1 (6%)
Admitted to a NICU/SCBU 0 0 1 (5%) 2 (9%) 1 (6%)
Survived to discharge 0 0 0 0 0 
Infants born at 23 weeks gestation  
(23+0 to 23+6) in ROI 
A total of 27 infants were born in 2018 in Ireland 
at 23 weeks gestation, the vast majority of these 
delivered in tertiary centres (n=24, 89%) (Table 5.7). 
Twenty-four of these infants (89%) were resuscitated 
in the delivery room, including 22 (92%) of the 
infants born in tertiary centres, one of the two 
infants born in a regional centre and one (the only) 
infant who was born in a peripheral centre. Of these 
infants who received resuscitation in the delivery 
room, only the 22 infants born in tertiary centres 
survived to admission to a NICU/SCBU. 
Five of the 27 infants born at 23 weeks gestation 
died in the delivery room.
Of the 22 infants who survived to admission to a 
NICU/SCBU, none was transferred from their hospital 
of birth soon after they were born (Table 5.7). 
In total, nine infants born at 23 weeks gestation in 
2018 survived to discharge, all of these were born 
in tertiary centres (Table 5.7). The overall crude 
survival rate for infants of this gestational age was 
33% (n=9/27). 
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Liveborn infants 24 2 1 27
Received resuscitation in the delivery room 22 (92%) 1 (50%) 1 (100%) 24 (89%)
Admitted to a NICU/SCBU 22 (92%) 0 (0%) 0 (0%) 22 (81%)
Transferred to another neonatal centre within 
48 hours of birth 
0 (0%) 0 (0%) 0 (0%) 0 (0%)
Survived to discharge among liveborn babies 9/24 (38%) 0/2 (0%) 0/1 (0%) 9/27 (33%)
Survived to discharge among infants receiving 
resuscitation
9/22 (41%) 0/1 (0%) 0/1 (0%) 9/24 (33%)
Survived to discharge among infants admitted 
to NICU/SCBU
9/22 (41%) 0/0 (0%) 0/0 (0%) 9/22 (33%)
The figures in table 5.8 show an increase, over the past 4 years, in the proportion of infants born at 23 
weeks gestation who were resuscitated in the delivery room and admitted to a NICU/SCBU. Despite this, 
in 2018, the number of infants born at this gestational age and who survived to discharge was lower. 











Liveborn infants 21 30 27 15 27
Received resuscitation in the delivery room 9 (42%) 22 (73%) 20 (74%) 13 (87%) 24 (89%)
Admitted to a NICU/SCBU 5 (24%) 10 (33%) 20 (74%) 13 (87%) 22 (81%)
Survived to discharge 4 (19%) 9 (30%) 10 (37%) 7 (47%) 9 (33%)
Table 5.9 displays Standardised Mortality/Morbidity Ratios (SMR = Observed/Expected) for the main 
KPIs recorded for the infants born in ROI between 2014 and 2018, at 23 weeks of gestation. Necrotising 
Enterocolitis (NEC) was the only one of the KPIs analysed here with an observed number of cases in Ireland 
that was notably different than the expected number. Out of 80 infants for whom NEC was determined, 
there were 16 cases observed, almost twice the expected number of nine (SMR 1.78; CI 1.13, 2.43). This 
difference was statistically significant but it must be noted that the numbers involved are relatively small. 
Table 5.9: Risk Adjusted Standardised Mortality/Morbidity Ratios for Key Performance Indicators within infants 
born with 23 weeks of gestation in ROI, 2014-2018. 
Outcome N O E SMR (95% CI) O-E (95% CI)
Mortality 120 81 68 1.19 (0.95, 1.42) 13 (-3, 29)
Death or Morbidity 120 116 111 1.04 (0.86, 1.23) 5 (-16, 26)
Chronic Lung Disease 36 32 29 1.10 (0.74, 1.47) 3 (-8, 14)
Pneumothorax 80 9 9 1.01 (0.36, 1.67) 0 (-6, 6)
Any Late Infection 70 27 27 1.00 (0.62, 1.37) 0 (-10, 10)
Severe Intraventricular Haemorrhage 75 23 26 0.90 (0.51, 1.29) -3 (-12, 7)
Cystic Periventricular Leukomalacia 75 2 5 0.40 (0, 1.28) -3 (-7, 1)
Necrotising Enterocolitis 80 16 9 1.78* (1.13, 2.43) 7 (1, 13)
N specifies how many of the 120 infants had data on the KPI. Morbidities may not be recorded for infants who died, especially 
those who die soon after birth. O refers to the number of observed cases with the outcome and E to the expected number 
with the outcome of ROI infants with birth weights 501-1500g. 95% confidence intervals (CIs) are provided for the SMR and the 
difference in observed and expected cases. *Indicates a statistically significant difference.
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Mortality risk among the 120 infants born at 23 
weeks of gestation was 1.19 times higher than 
expected in Ireland, however this was not a 
statistically significant difference. 
Outcomes of infants born at 24-27 weeks 
gestation according to category of 
neonatal centre 
The current Model of Care for Neonatal Services 
in Ireland recommends that infants born before 
reaching a gestational age of 28 weeks should 
ideally be delivered at one of the four tertiary 
neonatal centres.3 Overall, there were 191 infants 
born at 24-27 weeks gestation of whom 150 
(79%) were born in tertiary neonatal centres, 19 
(10%) in regional centres and 22 (12%) in one of 
the peripheral centres (Table 5.10; Figure 5.2). 
Of these 191 infants, 171 (90%) received 
resuscitation in the delivery room, including 134 
(89%) of the infants born in tertiary centres, 18 
(95%) of those born in regional centres and 19 
(86%) of the infants born in peripheral centres 
(Table 5.10). One of the infants who were offered 
resuscitation in the delivery room died in the 
delivery room. This infant was born at 24wks 
gestation in a tertiary centre (Figure 5.2) with an 
infant born at 24 weeks gestation and was not 
diagnosed with an MCA. 
Twenty infants did not receive resuscitation 
in the delivery room, 16 of these were born in 
tertiary centres, one in regional centres and three 
in peripheral centres. Three died in the delivery 
room (one case in a peripheral unit and two in 
tertiary centres) and two of these infants had 
an MCA. Of the 17 remaining cases, all of whom 
were admitted to a NICU/SCBU, 14 survived to 
discharge (Figure 5.2). The three infants who did 
not survive were born in tertiary units (n=2) and 
a regional centre (n=1) at 26, 27 and 24 weeks 
gestation (respectively) and one had an MCA. 
In total, four (1%) infants born at 24-27 weeks 
gestation died in the delivery room, one of whom 
was resuscitated. 
A total of 187 (98%) infants born at 24-27 weeks 
gestation survived to admission to a NICU/
SCBU. Of these 187 infants, 170 (91%) received 
resuscitation in the delivery room but the 
remaining 17 infants did not require resuscitation 
in the delivery room. One of these infants was 
born at 24 weeks, six at 25 weeks, three at 26 
weeks and the final seven at 27 weeks. Therefore, 
of 39 liveborn infants at 24 weeks, 1 infant (2.6%) 
did not require any resuscitation in the DR. At 25 
weeks, the figures were 6/41 (14.6%), at 26 weeks, 
3/54 (5.6%) and at 27 weeks, 7/52 (13.5%).
Fourteen of the 187 infants admitted to NICU 
(7% of those liveborn at 24-27 weeks gestation, 
n=191) were transferred from their hospital of 
birth within 48 hours of birth (Table 5.10). Eleven 
of these infants were born in peripheral centres, 
and three in a regional centre (Table 5.10, Figure 
5.2). All were transferred to tertiary neonatal 
centres, except one who was transferred to a 
regional centre within 48 hours of birth and all 
infants survived to discharge.
In total, 148 (80%) infants born at 24-27 weeks 
gestation survived to discharge. The crude 
survival rate was 77% (n=116) for those born in 
tertiary centres, 74% (n=14) for those born in 
regional centres and 82% (n=18) for those born in 
peripheral centres (Table 5.10). 
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Liveborn infants 150 19 22 191
Received resuscitation in the delivery room 134 (89%) 18 (95%) 19 (86%) 171 (90%)
Admitted to a NICU/SCBU 147 (98%) 19 (100%) 21 (95%) 187 (98%)
Transferred to another neonatal centre 
within 48 hours of birth 
0/150 (0%) 3/19 (16%) 11/22 (50%) 14/191 (7%)
Survived to discharge among liveborns 116/145* (77%) 14/19 (74%) 18/22 (82%) 148/186* (80%)
Survived to discharge among infants 
receiving resuscitation
104/129* (81%) 14/18 (78%) 16/19 (84%) 134/166* (72%)
Survived to discharge among infants 
admitted to NICU/SCBU
116/142* (79%) 14/19 (74%) 21/21 (100%) 151/182* (81%)
*Survival outcome unknown for five infants. These infants were all born in a tertiary neonatal centre and required resuscitation at 
birth (none of them had an MCA). 
The Standardised Mortality/Morbidity Ratios (SMR 
= Observed/Expected) for the main KPIs recorded 
for the infants born in ROI between 2014 and 2018, 
at 24-27 weeks of gestation are shown in Table 5.11. 
An excess risk that was statistically significant was 
observed with respect to four of the eight KPIs. 
Respectively, there were 22%, 33%, 24% and 72% 
greater risk in Ireland with respect to mortality 
(SMR=1.22; 95% CI: 1.07, 1.37), pneumothorax 
(SMR=1.33; 95% CI: 1.06, 1.59), any late infection 
(SMR=1.24; 95% CI: 1.09, 1.40) and necrotising 
enterocolitis (SMR=1.72; 95% CI: 1.49, 1.96).
Mortality data was available for 894 of the 900 
infants born at 24-27 weeks of gestation between 
2014 and 2018, of whom 213 died whereas the 
expected number was 175. Thus, an excess of 38 
infants died, which was statistically significant 
(95% CI: 12, 64). The excess of 18 infants affected 
by pneumothorax, 40 infants with any late 
infection and 49 infants with NEC was also 
statistically significant.
Cystic periventricular leukomalacia, determined 
for 830 of the 900 infants, was rare but the 
observed risk was approximately half that 
expected (SMR=0.52; 95% CI: 0.18, 0.86). There 
were 17 diagnosed cases compared to an expected 
number of 33, a statistically significant difference.
Table 5.11: Risk Adjusted Standardised Mortality/Morbidity Ratios for Key Performance Indicators within infants 
born with 24-27 weeks of gestation in ROI, 2014-2018. 
Outcome N O E SMR (95% CI) O-E (95% CI)
Mortality 894 213 175 1.22* (1.07, 1.37) 38 (12, 64)
Death or Morbidity 887 617 597 1.03 (0.95, 1.11) 20 (-28, 68)
Chronic Lung Disease 639 296 274 1.08 (0.96, 1.20) 22 (-11, 54)
Pneumothorax 869 74 56 1.33* (1.06, 1.59) 18 (4, 33)
Any Late Infection 796 204 164 1.24* (1.09, 1.40) 40 (15, 65)
Severe Intraventricular Haemorrhage 817 123 103 1.19* (1.00, 1.38) 20 (0, 40)
Cystic Periventricular Leukomalacia 830 17 33 0.52* (0.18, 0.86) -16 (-27, -5)
Necrotising Enterocolitis 869 116 67 1.72* (1.49, 1.96) 49 (33, 65)
N specifies how many of the 900 infants had data on the KPI. Morbidities may not be recorded for infants who died, especially 
those who die soon after birth. “O” refers to the number of observed cases with the outcome and E to the expected number 
with the outcome of ROI infants with birth weights 501-1500g. 95% confidence intervals (CIs) are provided for the SMR and the 
difference in observed and expected cases. 















































































Figure 5.2: Flow chart illustrating survival outcomes of VLBW born at 24–27 weeks gestation according to 
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Outcomes of infants born at 28-31 
weeks gestation according to category 
of neonatal centre
Overall, there were 232 infants born at 28-
31 weeks gestation of which, 152 (6%) were 
born in tertiary neonatal centres, 63 (30%) 
in regional centres and 17 (10%) in peripheral 
centres (Table 5.12; Figure 5.3). 
Of these 232 infants, 161 (69%) received 
resuscitation in the delivery room, which 
included 102 (67%) infants born in tertiary 
centres, 46 (73%) infants born in regional 
centres and 13 (76%) infants born in peripheral 
centres. All of these infants survived to 
admission to a NICU/SCBU, 17 of these infants 
had an MCA. 
A total of 71 infants did not receive 
resuscitation in the delivery room (50 born 
in tertiary centres, 17 born in regional centres 
and 4 born in peripheral centres) (Figure 
5.3). Three of these infants were transferred 
to other units within 48 hours of being born 
and the remaining 68 of these infants were 
subsequently admitted to a NICU/SCBU and all 
survived to discharge. 
None of the infants born at 28-31 weeks 
gestation died in the delivery room (Table 5.11; 
Figure 5.3).
All the 232 infants born at 27-29 weeks 
gestation were admitted to a NICU/SCBU 
including 15 (7% of the total 232 born) infants 
who were subsequently transferred within 48 
hours. Twelve of these where transferred from 
peripheral centres, two from a regional centre 
and one from a tertiary centre. All of the 15 
infants who were transferred survived (Figure 
5.3). 
A total of 217 (94%) infants born at 27-
29 weeks gestation survived to discharge 
(information on survival outcome not available 
for one infant): 141 (93%) of those born in 
tertiary centres, 59 (94%) of those born in 
regional centres and 17 (100%) of those born in 
peripheral centres (Table 5.12). 











Liveborn infants 152 63 17 232
Received resuscitation in the delivery room 102 (67%) 46 (73%) 13 (76%) 161 (69%)
Admitted to a NICU/SCBU 152 (100%) 63 (100%) 17 (100%) 232 (100%)
Transferred to another neonatal centre 
within 48 hours of birth 
1/152 (1%) 2/63 (3%) 12/17 (71%) 15/232 (6%)
Survived to discharge 141/151* (93%) 59/63 (94%) 17/17 (100%) 217/231* (94%)
Survived to discharge among infants 
receiving resuscitation
91/151* (60%) 42/63 (91%) 13/17 (100%) 146/160* (63%)
Survived to discharge among infants 
admitted to NICU/SCBU
151/151* (100%) 59/63 (94%) 17/17 (100%) 217/231* (94%)
*Survival outcome unknown for one infant, born in a tertiary neonatal centre, who required resuscitation, was not transferred 
within 48h of birth and had an MCA. 
The Standardised Mortality/Morbidity Ratios (SMR = Observed/Expected) for the main KPIs recorded 
for the 1,446 infants born in ROI between 2014 and 2018 at 28-31 weeks of gestation are shown in Table 
5.13. An excess risk that was statistically significant was observed with respect to two of the eight KPIs. 
There was 19% higher risk in Ireland with respect to death or specified morbidity (SMR=1.19; 95% CI: 
1.09, 1.29). Risk of pneumothorax was more than twice that expected based on the profile of the infants 
(SMR=2.25; 95% CI: 1.95, 2.56). 
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Table 5.13: Risk Adjusted Standardised Mortality/Morbidity Ratios for Key Performance Indicators within infants 
born with 28-31 weeks of gestation in ROI, 2014-2018.
Outcome N O E SMR (95% CI) O-E (95% CI)
Mortality 1398 83 69 1.21 (0.97, 1.45) 14 (-2, 31)
Death or Morbidity* 1441 449 378 1.19 (1.09, 1.29) 71 (33, 109)
Chronic Lung Disease 1331 173 169 1.02 (0.87, 1.17) 4 (-22, 29)
Pneumothorax* 1430 93 41 2.25 (1.95, 2.56) 52 (39, 64)
Any Late Infection 1380 109 99 1.11 (0.91, 1.3) 10 (-9, 30)
Severe Intraventricular Haemorrhage 1352 37 37 1.01 (0.69, 1.33) 0 (-12, 12)
Cystic Periventricular Leukomalacia 1394 28 26 1.10 (0.71, 1.49) 2 (-7, 12)
Necrotising Enterocolitis 1429 42 51 0.83 (0.55, 1.11) -9 (-23, 5)
N specifies how many of the 1446 infants had data on the KPI. Morbidities may not be recorded for infants who died, especially 
those who die soon after birth. O refers to the number of observed cases with the outcome and E to the expected number with 
the outcome of ROI infants born at 28-31 weeks of gestation. 95% confidence intervals (CIs) are provided for the SMR and the 
difference in observed and expected cases. 
*Indicates a statistically significant difference. 
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Figure 5.3: Flow chart illustrating survival outcomes of VLBW born at 28-31 weeks gestation 
























































































Outcomes of infants born ≥32 weeks 
gestation according to category of 
neonatal centre 
There were 70 infants born at ≥32 weeks 
gestation in 2018, 53 (75%) of these were born 
in tertiary neonatal centres, 15 (21%) in regional 
neonatal centres and 2 (3%) in one of the 
peripheral centres (Table 5.14). 
A total of 28 (40%) infants required resuscitation 
in the delivery room, including 19 (36%) infants 
born in tertiary centres, 8 (53%) infants born 
in regional centres and 1 (50%) infant born in a 
peripheral centre. All survived to admission to 
a NICU/SCBU and two (infants born in tertiary 
units) died before discharge, (information on 
survival outcome not known for one infant). One 
baby, born in a tertiary centre was transferred to 
paediatric hospital within 48 hours of birth. This 
infant had a MCA. 












Liveborn infants 53 15 2 70
Received resuscitation in the delivery room 19 (36%) 8 (53%) 1 (50%) 28 (40%)
Admitted to a NICU/SCBU 48 (91%) 15 (100%) 2 (100%) 65 (93%)
Transferred to another neonatal centre 
within 48 hours of birth 
1/53 (0%) 0/15 (0%) 0/2 (0%) 1/70 (1%)
Survived to discharge 44/52* (85%) 15/15 (100%) 2/2 (100%) 61/69* (88%)
Survived to discharge among infants 
receiving resuscitation
16/18* (89%) 8/8 (100%) 1/1 (100%) 25/27* (36%)
Survived to discharge among infants 
admitted to NICU/SCBU
44/47* (94%) 15/15 (100%) 2/2 (100%) 61/64* (88%)
*Survival outcome unknown for one infant, born in a tertiary neonatal centre, who required resuscitation, was transferred 
within 48h of birth and had an MCA. 
The other 42 infants born at ≥32 weeks gestation 
did not receive resuscitation in the delivery room 
(34 born in tertiary centres, 7 born in regional 
centres and 1 born in peripheral centres). Five 
of these infants died in the delivery room (all 
of them in tertiary centres) and all of these 
infants had an MCA. The remaining 37 infants 
who did not receive resuscitation were admitted 
to a NICU/SCBU and all but one survived to 
discharge. Two of these infants were born with 
MCA and only one survived to discharge. 
Overall, 65 (93%) infants ≥32 weeks gestation 
were admitted to a NICU/SCBU. Survival 
outcome is not known for one baby (born in a 
tertiary centre). Of the remaining 64 infants, all 
but three infants survived to discharge. These 
three infants were born in tertiary centres. Two of 
the infants who died had an MCA (Table 5.14). 
A total of 61 (88%) infants born at ≥32 weeks 
gestation survived to discharge (survival 
outcome unknown for one infant): 44 (85%) of 
those born in tertiary centres, 15 (100%) of those 
born in regional centres and 2 (100%) of those 
born in peripheral centres (Table 5.14). 
The Standardised Mortality/Morbidity Ratios 
(SMR = Observed/Expected) for the main KPIs 
recorded for the 395 very low birth weight 
infants born in ROI between 2014 and 2018 at 32 
or more weeks of gestation are shown in Table 
5.15. No statistically significant differences were 
evident between the observed and expected 
number of cases for each of the eight KPIs.
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Table 5.16: Survival rates for gestational age categories of VLBW infants born in the ROI according to category of 












Median % Q1 Q3
≤ 22 weeks 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0% 0% 18%
23 weeks 9 (38%) 0 (0%) 0 (0%) 9 (33%) 43% 0% 67%
24-26 weeks 83 (78%) 9 (64%) 10 (71%) 102 (76%) 79% 67% 91%
27-29 weeks 117 (91%) 40 (97%) 24 (100%) 181 (94%) 96% 90% 100%
30-32 weeks 82 (92%) 33 (100%) 3 (100%) 118 (83%) 100% 95% 100%
>32 weeks 310 (79%) 6 (100%) 0 (0%) 25 (83%) 100% 100% 100%
Total 310 (80%) 88 (87%) 37 (88%) 435 (82%) 88% 83% 93%
Note: N represents the total number of very low birth weight babies (VLBW) in Ireland. For Ireland the % is based on the cases as 
the numerator and the total, N, as the denominator. For VON the total number of VLBW infants with information available survival 
by gestational age was 61,484. The VON reports the Median % based on the units that submit data, as outlined in the methods 
section. Half of the units report a % lower than the median, one quarter of the units report a % lower than Q1 and three quarters of 
the units report a % lower than Q3. 
Table 5.15: Risk Adjusted Standardised Mortality/Morbidity Ratios for Key Performance Indicators within infants 
born with 32 or more weeks of gestation in ROI, 2014-2018. 
Outcome N O E SMR (95% CI) O-E (95% CI)
Mortality 392 28 28 1.00 (0.63, 1.37) 0 (-10, 10)
Death or Morbidity 394 52 66 0.79 (0.55, 1.04) -14 (-29, 2)
Chronic Lung Disease 370 20 27 0.73 (0.36, 1.11) -7 (-18, 3)
Pneumothorax 379 2 5 0.36 (0, 1.20) -3 (-8, 1)
Any Late Infection 374 9 13 0.70 (0.15, 1.25) -4 (-11, 3)
Severe Intraventricular Haemorrhage 303 2 2 0.92 (0, 2.25) 0 (-3, 3)
Cystic Periventricular Leukomalacia 328 2 3 0.66 (0, 1.79) -1 (-4, 2)
Necrotising Enterocolitis 378 5 7 0.76 (0, 1.53) -2 (-7, 3)
N specifies how many of the 395 infants had data on the KPI. Morbidities may not be recorded for infants who died, especially 
those who die soon after birth. O refers to the number of observed cases with the outcome and E to the expected number with 
the outcome of ROI infants born at 32 or more weeks of gestation. 95% confidence intervals (CIs) are provided for the SMR and 
the difference in observed and expected cases. 
*Indicates a statistically significant difference.
Summary survival outcomes of infants according to category of neonatal centre
Table 5.16 summarises the survival outcome of infants in the different gestational age categories 
according to birth location/category of neonatal centre. As rates are based on small numbers, 
particularly at the lower gestational ages, firm conclusions cannot be drawn from a single year of data. 
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6. Total Mortality and Mortality Excluding Early Death 
In 2018, a total of 18% (n=95) of VLBW babies 
born in the ROI died (VON Median 13%; Q1=8%, 
Q3=18%). Among these ROI infants, 8% died 
either in the Delivery Room (6%, n=30) or within 
12 hours of admission to the NICU (2%, n=8; 
Figure 6.1). After excluding early deaths, a further 
11% (n=57) of ROI infants died after 12 hours of 
age (VON Median 8%; Q1=4%, Q3=13%). This 
pattern of mortality in both the ROI and in VON 
is similar to that observed in previous years.2, 4, 5 
Figure 6.1: Comparison of mortality amongst ROI and VON infants, 2018.
Note: Dark blue bar represents the interquartile range for units reporting to the VON. The dark blue horizontal marker indicates 
the median of units reporting to the VON. 
Table 6.1: Mortality amongst Republic of Ireland and VON infants, 2018. 
Republic of Ireland VON
Cases N % Median % Q1 Q3
Died in DR 30 537 6% 0% 0% 5%
Died within 12 Hours 8 507 2% 0% 0% 2%
Mortality Excl. Early Deaths 57 530 11% 8% 4% 13%
Total Mortality 95 530 18% 13% 8% 18%
Note: N represents the total number of very low birth weight babies (VLBW) in Ireland. For Ireland the % is based on the cases 
as the numerator and the total, N, as the denominator. For VON the total number of VLBW infants with information available on 
each characteristic reported ranged between 58,807 and 62,135. The VON reports the Median % based on the units that submit 
data, as outlined in the methods section. Half of the units report a % lower than the median, one quarter of the units report a % 
lower than Q1 and three quarters of the units report a % lower than Q3. 
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Deaths in the Delivery Room in 2018
In 2018, 6% (n=30) ROI infants died in the DR 
(VON Median 0%; Q1=0%, Q3=5%). Hence, 
at least 75% of the VON units had a lower 
percentage of deaths in the Delivery room 
compared to ROI. The proportion of infants dying 
in the delivery room in 2018 in ROI was similar to 
that reported in the preceding years (6% in 2017 
and 2016). 
Of the 30 infants who died in the delivery 
room in 2018, 7 (23%) had a major congenital 
anomaly (Table 6.2). In total, 28 of 30 (93%) 
infants who died in the delivery room in the ROI 
in 2018 had either an MCA or were less than 24 
weeks gestation. This is similar to the analogous 
proportions of 84% in 2017, 91% in 2016, 89% in 
2015 and 86% in 2014. 
As previously mentioned in section 2, (and 
Table 2.1, page 15), ROI infants were significantly 
more likely to be born with MCA compared to 
VON (8% in ROI compared to the VON Median 
4% VON in 2018; Q1=0%, Q3=8%) and this 
factor is very likely to have impacted on the 
higher delivery room death rate seen in the ROI 
population. 
A further 23 infants (77%), 21 (91%) of whom 
were born <24 weeks, died in the DR in 2018 and 
did not have an MCA. Of these 21 infants, 5 were 
born at 21 weeks, 11 at 22 weeks and five were 23 
weeks gestation.
Table 6.2: Deaths in the delivery room, by gestational age category and presence of major congenital anomaly, 
2018, n=30.





< 24 weeks 21 0 21
24-26 weeks 2 1 3
27-29 weeks 0 1 1
30-32 weeks 0 2 2
> 32 weeks 0 3 3
Total 23 7 30
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•  In 2018, the overall survival rate of VLBW 
infants born in Ireland was 82% (435 
infants of a total of 530). These values, 
although equal to the previous year, 
represent a marginal decrease of 2% in 
the survival rates for ROI infants when 
compared to 2015 and 2016. 
•  Similar to previous years, a higher 
proportion of ROI infants died in the 
delivery room (6%, n=30) when compared 
to VON (median 0%; Q1=0%, Q3=4.5%).
•  The mortality risk in 2018 was consistent 
with the risk observed in the previous 
three years. It was 11% higher than 
expected after adjusting for the risk profile 
of the population (SMR=1.11; CI 0.87, 1.36). 
The findings were similar when mortality 
excluding early deaths was considered 
(SMR=1.12; CI 0.83, 1.41). 
•  The risk of ROP among VLBW infants in 
ROI continues to be lower than expected, 
albeit by a smaller percentage in 2018 
(SMR=0.85; CI 0.67, 1.04) compared to 
previous years but the risk of severe 
ROP was statistically significantly lower 
(SMR=0.39; CI 0.00, 0.83).
•  ROI Infants continue to show a statistically 
higher rate of pneumothorax compared to 
VON (SMR=1.56; CI 1.13, 1.98), a consistent 
finding since 2014. Infants born at 28-31 
weeks gestation were showed to have 
more than twice the expected risk of 
having a pneumothorax (SMR=2.25; 95% 
CI: 1.95, 2.56). 
•  A statistically significant decrease in all 
KPIs was observed with higher gestational 
ages. This denotes a lower percentage of 
mortality, morbidity and specific outcomes 
(as measured by the KPIs) for infants born 
with higher gestational ages. 
•  Since 2014, there has been a steady 
increase in the number of infants born 
at 23 weeks who are resuscitated in the 
delivery room (from 42% in 2014 to 89% in 
2018) and this had been associated with 
an increase in the number of these infants 
who survive to discharge (from 19% in 
2014, to 47% in 2017 and 33% in 2018). 
•  A total of 47 (20%) of ROI infants <28 
weeks gestation were born outside tertiary 
neonatal centres in 2018, 14 of these 
infants were transferred within 48 hours of 
being born.
In Summary 
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healthcare to improve the quality of care through national clinical audit. 
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Appendix A: Endorsement by the National 
Office of Clinical Audit (NOCA)
      
National Office of Clinical Audit 
2nd Floor 
Ardilaun House, Block B 
111 St Stephen’s Green 
Dublin 2, D02 VN51 
Tel: + (353) 1 402 8577 
Email: auditinfo@noca.ie 
 
Dr Anne Twomey  
Consultant Neonatologist  
Dr Brendan Paul Murphy  
Consultant Neonatologist  
National Maternity Hospital  Cork University Maternity Hospital  




07 August, 2020 
 
 
Re: Very Low Birth Weight Infants in the Republic of Ireland - Annual Report 2018 
 
 
Dear Drs Twomey and Murphy,  
 
We thank you for the presentation by Professor Richard Greene and Dr Paul Corcoran to the NOCA 
Governance Board on 25 June, 2020.   
 
On behalf of the NOCA Governance Board, I wish to congratulate you, the Neonatal Intensive Care 
Outcomes Research and Evaluation (NICORE) group and the National Perinatal Epidemiology Centre 
(NPEC) and all participating neonatal units for your combined efforts in initiating and supporting this 
valuable quality improvement initiative.    
 
On behalf of the NOCA Governance Board, I am happy to endorse the Very Low Birth Weight Infants 







Dr Brian Creedon  
Clinical Director 
National Office of Clinical Audit Governance Board 
 
c.c. Prof Richard Greene, National Perinatal Epidemiology Centre, CUMH, Cork 
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Appendix B: VON unit leads and co-ordinators 
and contributors 2018
Neonatal Unit Leads Co-ordinators
Cavan General Hospital Dr Alan Finan Ms Evelyn McAdam 
Coombe Women and Infants University Hospital Dr John Kelleher Ms Julie Sloan
Cork University Maternity Hospital Dr Brendan Paul Murphy Dr Brendan Paul Murphy
Kerry General Hospital, Tralee Dr Akhtar Khan Ms Margaret Kelly
Letterkenny General Hospital Dr Mathew Thomas
Ms Kate Greenough 
Ms Marion Doogan
Mayo General Hospital, Castlebar Dr Hilary Stokes Dr Hilary Stokes
Midland Regional Hospital, Mullingar Dr Michael O’Grady Ms Geraldine Kavanagh
Midland Regional Hospital, Portlaoise Dr Anne Doolan
Dr Rizwan Gul 
Ms Anne Blanche
University Maternity Hospital, Limerick Dr Niazy Al-Assaf Ms Elizabeth Reidy
National Maternity Hospital, Dublin Dr Anne Twomey Mr John Geoghegan
Our Lady of Lourdes Hospital, Drogheda Dr Emma Gordon Claire Shannon
Portiuncula Hospital, Ballinasloe Dr Paula Cahill Dr Paula Cahill
Rotunda Hospital, Dublin Dr David Corcoran Ms Kathy Conway 
Sligo General Hospital
Dr Hilary Greaney 
Dr Ghia Harrison
Ms Madeleine Munelly 
Ms Niamh McGarvey
South Tipperary General Hospital, Clonmel Dr Justin Roche Dr Justin Roche
St Luke’s Hospital, Kilkenny Dr David Waldron Dr David Waldron
University Hospital Galway Dr Donough O’Donovan Dr Donough O’Donovan
Waterford Regional Hospital Dr Animitra Das Dr Shammaz Saeed
Wexford General Hospital Dr Muhammad Azam Dr Naeem Aziz Shori
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Appendix C: Vermont Oxford Network 
Data Collection Forms, 2018
Rel 22.0                                             Copyright ©2017 Vermont Oxford Network, Inc.   All Rights Reserved.         1 
VERMONT OXFORD NETWORK 
PATIENT DATA BOOKLET FOR INFANTS BORN IN 2018 
Contents:
Page 1:          Patient Identification Worksheet 
Page 2:          Length of Stay Calculation Worksheet 
Page 3 - 6: General Data Items
Page 7:          Transfer & Readmission Data Items (only infants who transfer to another hospital)
Page 8:          Supplemental Data Items (Expanded Database only)
Patient’s Name: _________________________________________
Mother’s Name: _________________________________________
Patient’s Medical Record Number: ________________________________
Date of Birth:   _____/_____/_____
    MM         DD      YYYY
Date of Admission:  _____/_____/_____ For inborn infants, the date of admission is the Date of Birth.
MM          DD       YYYY    For outborn infants, the date of admission is the date the infant was admitted to 
          your hospital.
Date of Day 28:  ____/____/____
MM      DD     YYYY      
Date of Week 36:  ____/____/____
     MM      DD     YYYY 
Date of Initial Disposition: _____/_____/_____  
                                                              MM         DD        YYYY 
If Infant Transferred: Date Discharged Home, Died, or First Birthday (if still hospitalized),
         whichever is soonest:      _____/_____/_____ 
                                    MM         DD        YYYY  
PLEASE DO NOT SUBMIT THIS WORKSHEET
Protected Health Care Information
PATIENT IDENTIFICATION WORKSHEET
This Worksheet contains protected health care information and must NOT be submitted to 
Vermont Oxford Network (VON). VON only accepts protected health care information in 
cases where members have both voluntarily elected to send this information to VON and
have signed an appropriate Business Associate Agreement with VON.
Network ID Number:Center Number:__________
Use the Calculation Charts for Date of Day 28 
and Date of Week 36 for the infant’s birth year.
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     5 7 Day #
   1   3 Day #
     4   4
          1
     4   5
SAMPLE CALCULATION OF INITIAL LENGTH OF STAY 
Enter Date of Initial Discharge, Transfer, or Death: 02 / 26 / 2018
Subtract Date of Admission:                                  01 / 13 / 2018                              ▬
Add 1: +
INITIAL LENGTH OF STAY =                                               Days
Explanation: Date of 02/26/2018 is Day Number 57.  Date of 01/13/2018 is Day Number 13. The day numbers for 
each date are found in the 2018-2019 Day Number Chart on the Network web site, www.vtoxford.org/downloads.
        
LENGTH OF STAY CALCULATION WORKSHEET 
FOR INFANTS BORN IN 2018
Protected Health Care Information. DO NOT SUBMIT this Worksheet to Vermont Oxford Network.
Use items Date of Admission, Date of Initial Disposition, and Date of Transfer/Discharge Home/Death/First 
Birthday from the Patient Identification Worksheet when completing this form.
Find day numbers corresponding to dates using the Day Number Chart for 2018-19 (www.vtoxford.org/downloads).
PLEASE DO NOT SUBMIT THIS WORKSHEET
Protected Health Care Information
Part A. Initial Length Of Stay
   
Enter Date of Initial Discharge, Transfer, or Death (Date of Initial Disposition): ____/____/____                Day #
Subtract Date of Admission to Your Hospital (Date of Admission):         ____/____/____   ▬ Day #
Add 1: + 1
                        
INITIAL LENGTH OF STAY = Days
Note: the maximum value of Initial Length of Stay is 366 (or 367 if leap day must be added), because tracking ends on the infant’s first birthday.
Part B. Total Length Of Stay
Only For Infants Transferred From Your Hospital to Another Hospital.
       
Enter Date of Final Discharge or Death (Transferred/Home/Died/1st Birthday): ____/____/____                   Day #
Subtract  Date of Admission (Date of Admission):                       ____/____/____ ▬        Day #
Add 1: +             1
TOTAL LENGTH OF STAY =                      Days
Note: the maximum value of Total Length of Stay is 366 (or 367 if leap day must be added), because tracking ends on the infant’s first birthday.
Network ID Number:  Center Number:________
For inborn infants, the date of admission is the Date of Birth.
For outborn infants, the date of admission is the date the infant was admitted to your hospital.
For inborn infants, the date of admission is the Date of Birth.
For outborn infants, the date of admission is the date the infant was admitted to your hospital.
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General Data Items - For Infants Born in 2018             
Center Number: ________      Network ID Number:               Year of Birth: ______
Birth Weight:      _______ grams   
Gestational Age Weeks: _______      Gestational Age Days (0-6): _______  
Died in Delivery Room: Yes No (If Yes, complete Delivery Room Death Data Items)
Location of Birth: Inborn Outborn
If Outborn, Day of Admission to Your Center (Range: 1 to 28.  Date of Birth is Day 1): _______
If Outborn, Transfer Code of Center from which Infant Transferred: __________
(List available at http://www.vtoxford.org/transfers)
Head Circumference at Birth (in cm to nearest 10th):             
Maternal Ethnicity/Race (Answer both Ethnicity and Race):
Ethnicity of Mother: Hispanic   Not Hispanic 
Race of Mother: Black or African American White Asian
American Indian or Alaska Native Native Hawaiian or Other Pacific Islander Other
Prenatal Care: Yes No
Antenatal Steroids: Yes No  
Antenatal Magnesium Sulfate: Yes No  
Chorioamnionitis: Yes No
Maternal Hypertension, Chronic or Pregnancy-Induced:          Yes No
Maternal Diabetes Yes No
Mode of Delivery: VaginaI Cesarean Section
Sex of Infant: Male Female Unknown
Multiple Gestation: Yes No If Yes, Number of Infants Delivered: _____
Congenital Infection: Yes No
Congenital Infection, Organism(s): _______________ _______________  _______________     
(If Congenital Infection is Yes, enter up to three Congenital Infection codes from Manual of Operations, Part 2 – Appendix E)
APGAR Scores: 1 minute _______ 5 minutes _______
Initial Resuscitation: Oxygen: Yes No       
Face Mask Vent: Yes No
Laryngeal Mask Airway:  Yes No
Endotracheal Tube Vent: Yes No       
Epinephrine: Yes No
Cardiac Compression: Yes No
Nasal Vent: Yes No
Nasal CPAP: Yes No
Temperature Measured within the First Hour after Admission to Your NICU: Yes    No        N/A                                                           
If Yes, Temperature Within the First Hour after Admission to Your NICU:
(In degrees centigrade to nearest 10th)           
Bacterial Sepsis and/or Meningitis on or before Day 3: Yes        No
Bacterial Sepsis and/or Meningitis on or before Day 3, Pathogen(s): ________ ________   ________        
(If Bacterial Sepsis and/or Meningitis is Yes, enter up to three Bacterial Pathogen codes from Manual of Operations, Part 2 – Appendix B)
▪
▪
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General Data Items - For Infants Born in 2018
Center Number: ________      Network ID Number:                Year of Birth: ______
Oxygen on Day 28: Yes            No N/A (See Manual of Operations, Part 2 for N/A criteria)
Periventricular-Intraventricular Hemorrhage (PIH):
      Cranial Imaging (US/CT/MRI) on or before Day 28: Yes No 
      If Yes, Worst Grade of PIH (0-4): _______
       If PIH Grade 1-4, Where PIH First Occurred:          Your Hospital Other Hospital
Died Within 12 Hours of Admission to Your NICU: Yes   No
Respiratory Support (at any time after leaving the delivery room/initial resuscitation area):
Oxygen after Initial Resuscitation: Yes No
Conventional Ventilation after Initial Resuscitation: Yes No
High Frequency Ventilation after Initial Resuscitation: Yes No
High Flow Nasal Cannula after Initial Resuscitation: Yes No
Nasal Ventilation after Initial Resuscitation: Yes No
Nasal CPAP after Initial Resuscitation: Yes No
Nasal CPAP or Nasal Vent before or without ever having received ETT Vent: Yes No N/A
Surfactant during Initial Resuscitation: Yes No
Surfactant at Any Time: Yes  No (Surfactant an Any Time must be Yes if Surfactant During Initial Resuscitation is Yes)
If Yes, Age at First Dose of Surfactant: Hours _____ Minutes (0-59) _____ 
Inhaled Nitric Oxide: Yes No
If Yes, Inhaled Nitric Oxide, Where Given: Your Hospital Other Hospital     Both
Respiratory Support at 36 Weeks (See Manual of Operations, Part 2 for N/A criteria):
Oxygen at 36 Weeks: Yes  No    N/A
Conventional Ventilation at 36 Weeks: Yes  No    N/A
High Frequency Ventilation at 36 Weeks: Yes  No    N/A
High Flow Nasal Cannula at 36 Weeks: Yes  No    N/A
Nasal Ventilation at 36 Weeks: Yes  No    N/A
Nasal CPAP at 36 Weeks:     Yes  No    N/A
Steroids for CLD: Yes  No    
If Yes, Steroids for CLD, Where Given: Your Hospital Other Hospital     Both
Indomethacin for Any Reason: Yes  No
Ibuprofen for PDA: Yes No
Acetaminophen (Paracetamol) for PDA: Yes No
Probiotics: Yes No
Treatment of ROP with Anti-VEGF Drug: Yes No
Caffeine for Any Reason: Yes No
Intramuscular Vitamin A for Any Reason: Yes No
ROP Surgery: Yes  No
If Yes, ROP Surgery, Where Done: Your Hospital Other Hospital     Both
Surgery or Interventional Catheterization for Closure of PDA:       Yes  No
     (If Yes, a Surgery Code, Location of Surgery, and an answer to Surgical Site Infection are required at the top of the next page)
Surgery for NEC, Suspected NEC, or Bowel Perforation: Yes  No
     (If Yes, a Surgery Code, Location of Surgery, and an answer to Surgical Site Infection are required at the top of the next page)
Other Surgery: Yes  No
     (If Yes, a Surgery Code, Location of Surgery, and an answer to Surgical Site Infection are required at the top of the next page)
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General Data Items - For Infants Born in 2018
Center Number: ________      Network ID Number:                Year of Birth: ______
If Yes to Surgery for Closure of PDA, Surgery for NEC, or Other Surgery, enter up to 10 Surgery Codes,
Locations of Surgery, and check Yes or No for Surgical Site Infection following Surgery at Your Hospital:
See Manual of Operations, Part 2 – Appendix D for Surgery Codes.
If Surgery for NEC is Yes, one or more of the following codes is required: S302, S303, S307, S308, S309, S333. 
Indicate Location of Surgery for each surgery code.
If a surgical site infection is present, indicate “Yes” for the one surgical code that resulted in the surgical site infection.
Surgery Code 1: ____________  Your Hospital     Other Hospital     Both Surgical Site Infection:    Yes   No
Surgery Code 2: ____________  Your Hospital     Other Hospital     Both Surgical Site Infection:    Yes   No
Surgery Code 3: ____________  Your Hospital     Other Hospital     Both Surgical Site Infection:    Yes   No
Surgery Code 4: ____________  Your Hospital     Other Hospital     Both Surgical Site Infection:    Yes   No
Surgery Code 5: ____________  Your Hospital     Other Hospital     Both Surgical Site Infection:    Yes   No
Surgery Code 6: ____________  Your Hospital     Other Hospital     Both Surgical Site Infection:    Yes   No
Surgery Code 7: ____________  Your Hospital     Other Hospital     Both Surgical Site Infection:    Yes No
Surgery Code 8: ____________  Your Hospital     Other Hospital     Both Surgical Site Infection:    Yes   No
Surgery Code 9: ____________ Your Hospital     Other Hospital     Both Surgical Site Infection:    Yes   No
Surgery Code 10: ___________  Your Hospital     Other Hospital     Both Surgical Site Infection:    Yes   No
Include description for Surgery Codes S100,S200,S300,S400,S500,S600,S700,S800,S900,S1000, and S1001:
Respiratory Distress Syndrome: Yes   No
Pneumothorax:                             Yes   No
If Yes, Pneumothorax, Where Occurred: Your Hospital Other Hospital     Both   
Patent Ductus Arteriosus:           Yes   No
Necrotizing Enterocolitis: Yes   No
If Yes, NEC, Where Occurred: Your Hospital Other Hospital     Both
Focal Intestinal Perforation:    Yes   No
If Yes, Focal Intestinal Perforation, Where Occurred: Your Hospital Other Hospital     Both
Sepsis and/or Meningitis, Late (after day 3 of life) (See Manual of Operations, Part 2 for N/A criteria):
Bacterial Sepsis and/or Meningitis after Day 3:         Yes No     N/A
If Yes, Bacterial Sepsis and/or Meningitis after Day 3, Where Occurred:
Your Hospital Other Hospital     Both
Bacterial Sepsis and/or Meningitis after Day 3, Pathogen(s): ________     ________    ________    
(If Bacterial Sepsis and/or Meningitis is Yes, enter up to three Bacterial Pathogen codes from Manual of Operations, Part 2 – Appendix B)
Coagulase Negative Staph Infection after Day 3: Yes No N/A
If Yes, Coagulase Negative Staphylococcal Infection after Day 3, Where Occurred:
Your Hospital Other Hospital     Both
Fungal Infection after Day 3: Yes No     N/A
If Yes, Fungal Infection after Day 3, Where Occurred: Your Hospital Other Hospital     Both
Cystic Periventricular Leukomalacia:    Yes No N/A (See Manual of Operations, Part 2 for N/A criteria)
ROP, Retinal Examination Yes  No
If Yes, Worst Stage of ROP (0-5):      _____
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See Manual of Operations, Part 2 – Appendix C for Congenital Anomaly Codes. 
If Yes, as needed, include description(s) for Codes 100, 504, 601, 605, 901, 902, 903, 904, and 907: 
 
 
General Data Items - For Infants Born in 2018           
Center Number: ________      Network ID Number:                   Year of Birth: ______
Congenital Anomaly:     Yes    No
If Yes, enter up to five Congenital Anomaly Codes: _____   _____   _____   _____   ____
                                                                                                                                                                                  
Enteral Feeding at Discharge:
         None   
           Human Milk Only  
           Formula Only 
           Human milk in combination with either fortifier or formula
Oxygen, Respiratory Support, and Monitor at Discharge:
Oxygen at Discharge: Yes   No
Conventional Ventilation at Discharge: Yes   No
High Frequency Ventilation at Discharge: Yes   No
High Flow Nasal Cannula at Discharge:  Yes   No
Nasal Ventilation at Discharge: Yes   No
Nasal CPAP at Discharge: Yes   No
Monitor at Discharge:  Yes   No     
Initial Disposition (check only one):
         Home
         Died
         Transferred to another Hospital (When this Disposition is chosen, also complete Transfer & Readmission Data Items)
         Still Hospitalized as of First Birthday
Weight at Initial Disposition: _________ grams
Head Circumference at Initial Disposition (in cm to nearest 10th): 
Initial Length of Stay:  ________ day(s) (Data Item Initial Length of Stay on Length of Stay Calculation Worksheet)  
▪
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Transfer & Readmission Data Items - For Infants Born in 2018  
Center Number: ________      Network ID Number:                   Year of Birth: ______
Part A.  Complete for ALL Transferred Infants
If an infant is transferred to another hospital, complete Data Items Reason for Transfer, Transfer Code of Center to 
which Infant Transferred, and Post Transfer Disposition (below). Post Transfer Disposition refers to the infant's 
disposition upon leaving the "transferred to" hospital.  
Reason for Transfer: Growth/Discharge Planning Medical/Diagnostic Services 
     Surgery ECMO Chronic Care Other 
Transfer Code of Center to which Infant Transferred: _____________ (List available at https://www.vtoxford.org/tools/transferlist.aspx) 
Post Transfer Disposition (check only one):
Home        Skip Parts B and C. Complete Part D.
Transferred Again to Another Hospital (2nd Transfer) Skip Part B. Complete Parts C and D when data are available.
Died       Skip Parts B and C. Complete Part D.
Readmitted to Any Location in Your Hospital   Complete Parts B and D (and C if applicable) when data are available.
   Still Hospitalized as of First Birthday   Skip Parts B and C. Complete Part D. 
Part B.  Complete ONLY for Readmitted Infants
If a patient is readmitted to your center after transferring once to another hospital without having been home, answer
Data Items Disposition after Readmission and Weight at Disposition after Readmission (below). 
When infants are readmitted to your center, continue to update Items Bacterial Sepsis and/or Meningitis on or before 
Day 3 through PIH, Where First Occurred and Items Oxygen after Initial Resuscitation through Monitor at Discharge
based on all events at both hospitals until the date of Disposition after Readmission.
If your hospital participates in the Expanded Database and definition criteria are met, update Data Items ECMO at your 
Hospital, Hypothermic Therapy at Your Hospital, Cooling Method, Hypoxic-Ischemic Encephalopathy, HIE Severity,
and Seizures based on events that occur following transfer and readmission.
Disposition after Readmission (check only one):
Home        Skip Part C. Complete Part D. 
Died         Skip Part C. Complete Part D. 
Transferred Again to Another Hospital    Complete Parts C and D when data are available. 
Still Hospitalized as of First Birthday      Skip Part C. Complete Part D. 
Weight at Disposition after Readmission:  _________ grams
Part C.  Complete ONLY for Infants Who Transferred More Than Once
Answer Ultimate Disposition if an infant transferred from your center to another hospital and was then either (1) 
transferred again to another hospital, or (2) readmitted to your center and then transferred again to another hospital. 
Ultimate Disposition (check only one):
Home         Complete Part D. 
Died         Complete Part D.
Still Hospitalized as of First Birthday      Complete Part D.
  Part D. Complete for ALL Transferred Infants
Complete Total Length of Stay when the infant has been discharged Home, Died, or is Still Hospitalized as of First 
Birthday, whichever comes first.
Total Length of Stay: ________day(s)    (Data Item Total Length of Stay on Length of Stay Calculation Worksheet)
(Check Only One)
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Supplemental Data Items - For Infants Born in 2018
(For Expanded Data Submitting Centers) 
Center Number: ________      Network ID Number:                   Year of Birth: ______
Treatments:
Duration of Assisted Ventilation:  
           None                 <4 hours               4-24 hours              > 24 hours                 N/A
If > 24 hours, Total Days of Assisted Ventilation: _______
ECMO at your Hospital:   Yes   No   N/A
Hypothermic Therapy at Your Hospital:
Was Hypothermic Therapy Performed at Your Hospital:                   Yes   No
If Yes, Hypothermic Therapy Cooling Method: Selective Head Whole Body              Both
Diagnoses:
  
Hypoxic-Ischemic Encephalopathy:   Yes  No    N/A
HIE Severity (check one):   Mild  Moderate Severe N/A
Meconium Aspiration Syndrome:     Yes No    
Tracheal Suction for Meconium Attempted during Initial Resuscitation: Yes No   N/A
Seizures:         Yes No N/A
  
National Perinatal Epidemiology Centre, 
Department of Obstetrics and Gynaecology, UCC, 
5th Floor, Cork University Maternity Hospital,  
Wilton, Cork, Ireland. 
Tel: +353 21 4205017  
Email: npec@ucc.ie  
www.ucc.ie/en/npec/
